Infectious corneal ulceration: a proposal for neglected tropical disease status
Ung, Lawson Acharya, Nisha R. Agarwal, Tushar Alfonso, Eduardo C. Bagga, Bhupesh Bispo, Paulo J. M. Burton, Matthew J. Dart, John K. G. Thuy Doan Fleiszig, Suzanne M. J. Garg, Prashant Gilmore, Michael S. Gritz, David C. Hazlett, Linda D. Iovieno, Alfonso Jhanji, Vishal Kempen, John H. Lee, Cecilia S. Lietman, Thomas M. Margolis, Todd P. McLeod, Stephen D. Mehta, Jod S. Miller, Darlene Pearlman, Eric Prajna, Lalitha Prajna, N. Venkatesh Seitzman, Gerami D. Shanbhag, Swapna S. Sharma, Namrata Sharma, Savitri Srinivasan, Muthiah Stapleton, Fiona Tan, Donald T. H. Tandon, Radhika Taylor, Hugh R. Tu, Elmer Y. Tuli, Sonal S. Vajpayee, Rasik B. Van Gelder, Russell N. Watson, Stephanie L. Zegans, Michael E. Chodosh, James
Venkatesh Prajna Namperumalsamy
Namperumalsamy Venkatesh Prajna
ORCID: 0000-0003-2019-4044
Comparative Endothelial Toxicity of Differing Intracameral Moxifloxacin Doses Following Phacoemulsification 10.1097/j.jcrs.0000000000000064
Algorithm Variability in Quantification of Epithelial Defect Size in Microbial Keratitis Images 10.1097/ICO.0000000000002258
Infectious corneal ulceration: a proposal for neglected tropical disease status 10.2471/BLT.19.232660
Reply to Comment on: Visual Visual Impairment in Fungal Versus Bacterial Corneal Ulcers 4 Years After Successful Antimicrobial Treatment 10.1016/j.ajo.2019.10.001
Association of Postfungal Keratitis Corneal Scar Features With Visual Acuity 10.1001/jamaophthalmol.2019.4852
Commentary: Timing of therapeutic keratoplasty 10.4103/ijo.IJO_793_19
Demographic and socioeconomic barriers and treatment seeking behaviors of patients with infectious keratitis requiring therapeutic penetrating keratoplasty 10.4103/ijo.IJO_1821_18
Comparison of structural integrity and functional status of corneal endothelium stored in Cornisol and Optisol-GS 10.4103/ijo.IJO_2026_18
Traumatic corneal cyst 10.4103/ijo.IJO_1822_18
Quantitative profiling of tear proteome reveals down regulation of zinc alpha-2 glycoprotein in Aspergillus flavus keratitis patients 10.1016/j.exer.2019.107700
Cellular morphological changes detected by laser scanning in vivo confocal microscopy associated with clinical outcome in fungal keratitis 10.1038/s41598-019-44833-9
Colonization of therapeutic contact lens by dematiaceous fungi 10.1016/j.clae.2019.04.008
Toxic Keratitis After Application of Custard Apple Seed for Head Lice Infestation 10.1097/ICO.0000000000001981
Evaluation of computer-based retinopathy of prematurity (ROP) education for ophthalmology residents: a randomized, controlled, multicenter study 10.1016/j.jaapos.2018.11.008
Visual Impairment in Fungal Versus Bacterial Corneal Ulcers 4 Years After Successful Antimicrobial Treatment 10.1016/j.ajo.2019.03.010
Commentary: Procurement, storage and utilization trends of eye banks in India 10.4103/ijo.IJO_438_19
Descemet Membrane Suturing for Large Descemet Membrane Detachment After Cataract Surgery 10.1097/ICO.0000000000002113
Procurement, storage and utilization trends of eye banks in India 10.4103/ijo.IJO_1551_18
Human amniotic membrane as a drug carrier - An in-vitro study using fortified cefazolin ophthalmic solution 10.4103/ijo.IJO_1336_18
Commentary: Assessment of limbal ischemia in ocular burns 10.4103/ijo.IJO_1432_18
Pythium keratitis in South India: Incidence, clinical profile, management, and treatment recommendation 10.4103/ijo.IJO_445_18
The Asia Cornea Society Infectious Keratitis Study: A Prospective Multicenter Study of Infectious Keratitis in Asia 10.1016/j.ajo.2018.07.040
Take time to sharpen the saw 10.4103/ijo.IJO_739_18
In Vivo Confocal Microscopy Cellular Features of Host and Organism in Bacterial, Fungal, and Acanthamoeba Keratitis 10.1016/j.ajo.2018.03.010
Therapeutic Penetrating Keratoplasty Button Cultures in The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole Versus Placebo 10.1016/j.ajo.2018.05.007
Good quality pays rich dividends 10.4103/ijo.IJO_1246_17
Fungal keratitis caused by Laetisaria arvalis 10.4103/ijmm.IJMM_15_532
Reply to Comment on: Fungal keratitis: The Aravind Experience 10.4103/ijo.IJO_1163_17
Microsporidial infection masquerading as graft rejection post-Descemet's stripping automated endothelial keratoplasty 10.4103/ijo.IJO_295_17
Novel Image-Based Analysis for Reduction of Clinician-Dependent Variability in Measurement of the Corneal Ulcer Size 10.1097/ICO.0000000000001488
The Utility of Repeat Culture in Fungal Corneal Ulcer Management: A Secondary Analysis of the MUTT-I Randomized Clinical Trial 10.1016/j.ajo.2017.03.032
Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II 10.1001/jamaophthalmol.2017.2914
Persistence of Innate Immune Pathways in Late Stage Human Bacterial and Fungal Keratitis: Results from a Comparative Transcriptome Analysis 10.3389/fcimb.2017.00193
The Significance of Repeat Cultures in the Treatment of Severe Fungal Keratitis 10.1016/j.ajo.2018.02.003
Ocular manifestations of isolated corneal bee sting injury, management strategies, and clinical outcomes 10.4103/ijo.IJO_600_17
Evolution of Practice Patterns for the Treatment of Fungal Keratitis 10.1001/jamaophthalmol.2017.4763
Fungal keratitis: The Aravind experience 10.4103/ijo.IJO_821_17
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II 10.1001/jamaophthalmol.2017.0616
In vivo confocal microscopy appearance of Fusarium and Aspergillus species in fungal keratitis 10.1136/bjophthalmol-2016-309656
Comparison of In Vivo Confocal Microscopy, Ultrasonic Pachymetry, and Scheimpflug Topography for Measuring Central Corneal Thickness 10.1001/jamaophthalmol.2016.2183
A Prospective, In Vitro, Randomized Study to Compare Two Media for Donor Corneal Storage 10.1097/ICO.0000000000000912
In vivo Confocal Microscopic Analysis of Limbal Stroma in Patients With Limbal Stem Cell Deficiency 10.1097/ICO.0000000000000593
Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole 10.1136/bjophthalmol-2015-306828
Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I 10.1001/jamaophthalmol.2015.2040
Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial 10.1001/jamaophthalmol.2016.4096
Clinical and demographic study of microsporidial keratoconjunctivitis in South India: a 3-year study (2013-2015) 10.1136/bjophthalmol-2016-309845
Prospective Study of the Diagnostic Accuracy of the In Vivo Laser Scanning Confocal Microscope for Severe Microbial Keratitis 10.1016/j.ophtha.2016.07.009
Conjunctival Autograft Versus Amniotic Membrane Transplantation Following Double Pterygium Excision: A Randomized Trial 10.1097/ICO.0000000000001118
Trends in antibiotic resistance in bacterial keratitis isolates from South India 10.1136/bjophthalmol-2016-308487
Bilateral Atypical Granular Corneal Dystrophy Associated with Unilateral Keratoconus in a Male Child 10.4103/0974-9233.186151
Effect of pretreatment with antifungal agents on clinical outcomes in fungal keratitis 10.1111/ceo.12794
Conjunctival Autograft Versus Amniotic Membrane Transplantation After Double Pterygium Excision: A Randomized Trial 10.1097/ICO.0000000000000812
Clinical and microbiological study of paediatric infectious keratitis in South India: a 3-year study (2011-2013) 10.1136/bjophthalmol-2015-307631
Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial 10.1001/jamaophthalmol.2016.0530
Reply: To PMID 25841317 10.1016/j.ajo.2015.06.013
Corneal Cross-linking as an Adjuvant Therapy in the Management of Recalcitrant Deep Stromal Fungal Keratitis: A Randomized Trial 10.1016/j.ajo.2015.03.024
Severe Conjunctival Reaction Following Attempted Corneal Tattooing 10.1001/jamaophthalmol.2015.0934
Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial 10.1001/jamaophthalmol.2015.0319
In vivo confocal microscopic analysis of normal human anterior limbal stroma 10.1097/ICO.0000000000000369
Essential surgery: key messages from Disease Control Priorities, 3rd edition 10.1016/S0140-6736(15)60091-5
A case of bilateral, multiple, symmetric, concentric ring-shaped opacities in the cornea 10.1001/jamaophthalmol.2014.5379
Exoproteome of Aspergillus flavus corneal isolates and saprophytes: identification of proteoforms of an oversecreted alkaline protease 10.1016/j.jprot.2014.11.017
Trends in bacterial and fungal keratitis in South India, 2002-2012 10.1136/bjophthalmol-2014-305000
Interleukin 17 expression in peripheral blood neutrophils from fungal keratitis patients and healthy cohorts in southern India 10.1093/infdis/jiu381
Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis 10.1016/j.ophtha.2014.03.004
Visual outcomes in treated bacterial keratitis: four years of prospective follow-up 10.1167/iovs.14-13980
Visual recovery in treated bacterial keratitis 10.1016/j.ophtha.2013.12.041
Evaluation of fungal keratitis using a newly developed computer program, Optscore, for grading digital corneal photographs 10.3109/09286586.2013.868003
In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial 10.1016/j.ajo.2013.10.004
Voriconazole for fungal keratitis 10.1016/j.ophtha.2013.06.016
Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features 10.1016/j.ajo.2013.08.032
Differences in clinical outcomes in keratitis due to fungus and bacteria 10.1001/jamaophthalmol.2013.1612
Host response and bacterial virulence factor expression in Pseudomonas aeruginosa and Streptococcus pneumoniae corneal ulcers 10.1371/journal.pone.0064867
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole 10.1001/jamaophthalmol.2013.1497
Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I 10.1167/iovs.13-11716
Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial 10.1136/bjophthalmol-2012-301825
Identification of human corneal epithelial stem cells on the basis of high ABCG2 expression combined with a large N/C ratio 10.1002/jemt.22159
Investigation of VSX1 sequence variants in South Indian patients with sporadic cases of keratoconus 10.1186/1756-0500-6-103
Seasonal trends of microbial keratitis in South India 10.1097/ICO.0b013e31825694d3
Pantoea ananatis as a cause of corneal infiltrate after rice husk injury 10.1128/JCM.06743-11
Predictors of outcome in fungal keratitis 10.1038/eye.2012.99
The clinical differentiation of bacterial and fungal keratitis: a photographic survey 10.1167/iovs.11-8478
Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics 10.3109/09286586.2011.645990
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial 10.1097/ICO.0b013e31823f8ae0
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT) 10.1001/archophthalmol.2011.315
Gender differences in re-epithelialisation time in fungal corneal ulcers 10.1136/bjophthalmol-2011-300441
The steroids for corneal ulcers trial: study design and baseline characteristics 10.1001/archophthalmol.2011.303
Adult human buccal epithelial stem cells: identification, ex-vivo expansion, and transplantation for corneal surface reconstruction 10.1038/eye.2011.230
Comparative proteomics of human male and female tears by two-dimensional electrophoresis 10.1016/j.exer.2011.03.002
Expression of innate and adaptive immune mediators in human corneal tissue infected with Aspergillus or fusarium 10.1093/infdis/jir426
Clinical signs in dematiaceous and hyaline fungal keratitis 10.1136/bjo.2010.198648
Single and multidose ocular kinetics and stability analysis of extemporaneous formulation of topical voriconazole in humans 10.3109/02713683.2010.506968
Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis 10.1136/bjo.2010.195214
Comparison of natamycin and voriconazole for the treatment of fungal keratitis 10.1001/archophthalmol.2010.102
Susceptibility testing and clinical outcome in fungal keratitis 10.1136/bjo.2009.158675
Genetic analysis of patients with Fuchs endothelial corneal dystrophy in India 10.1186/1471-2415-10-3
Absence of phenotype-genotype correlation of patients expressing mutations in the SLC4A11 gene 10.1097/ICO.0b013e3181ae9038
Evaluation of the virtual mentor cataract training program 10.1016/j.ophtha.2009.07.009
A subset of human limbal epithelial cells with greater nucleus-to-cytoplasm ratio expressing high levels of p63 possesses slow-cycling property 10.1097/ICO.0b013e3181814ce6
Activity of antibiotics against Fusarium and Aspergillus 10.1136/bjo.2008.142364
In vitro natamycin susceptibility of ocular isolates of Fusarium and Aspergillus species: comparison of commercially formulated natamycin eye drops to pharmaceutical-grade powder 10.1128/JCM.00610-08
Corticosteroids for bacterial corneal ulcers 10.1136/bjo.2008.147298
Identification of mutations in the SLC4A11 gene in patients with recessive congenital hereditary endothelial dystrophy 10.1001/archopht.126.5.700
A method to isolate human limbal basal cells enriched for a subset of epithelial cells with a large nucleus/cytoplasm ratio expressing high levels of p63 10.1002/jemt.20573
Traumatic lenticular abscess: clinical description and outcome 10.1016/j.ajo.2007.02.040
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis 10.1001/archopht.125.6.789
Matrix metalloproteinases (MMP-8, MMP-9) and the tissue inhibitors of metalloproteinases (TIMP-1, TIMP-2) in patients with fungal keratitis 10.1097/01.ico.0000248384.16896.7d
Nocardia keratitis: species, drug sensitivities, and clinical correlation 10.1097/ICO.0b013e318033d853
Economic analysis of corneal ulcers in South India 10.1097/ICO.0b013e31802b36dc
Mutations in sodium-borate cotransporter SLC4A11 cause recessive congenital hereditary endothelial dystrophy (CHED2) 10.1038/ng1824
A pilot study on the infiltrating cells and cytokine levels in the tear of fungal keratitis patients 10.4103/0301-4738.29491
Antioxidants in prevention of cataracts in South India: methodology and baseline data* 10.1080/09286580500477366
Risk factors for treatment outcome in fungal keratitis 10.1016/j.ophtha.2005.10.063
The Antioxidants in Prevention of Cataracts Study: effects of antioxidant supplements on cataract progression in South India 10.1136/bjo.2005.088104
Rhodococcus ruber as a cause of keratitis 10.1097/01.ico.0000170690.59960.8c
Herpes simplex keratitis and visual impairment: a case series 10.4103/0301-4738.21610
High expression of p63 combined with a large N/C ratio defines a subset of human limbal epithelial cells: implications on epithelial stem cells 10.1167/iovs.05-0343
Economic cost of cataract surgery procedures in an established eye care centre in Southern India 10.1080/09286580490888762
Can antiseptic scrubs between cataract surgeries reduce bacterial load on surgical gloves to safe levels? 10.1136/bjo.2003.025437
Concurrent use of 5% natamycin and 2% econazole for the management of fungal keratitis 10.1097/01.ico.0000134193.64357.82
A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis 10.1136/bjo.87.10.1235
Acanthamoeba as a cause of peripheral ulcerative keratitis 10.1097/00003226-200308000-00018
Congenital corneal anesthesia: a series of four case reports 10.1097/00003226-200103000-00018
Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis 10.1097/00003226-200103000-00013
The madurai intraocular lens study IV: posterior capsule opacification 10.1016/s0002-9394(00)00481-5
Postcataract endophthalmitis in South India incidence and outcome 10.1016/j.ophtha.2005.05.020
Susceptibility trends of pseudomonas species from corneal ulcers 10.4103/0255-0857.16588
Outcomes of high volume cataract surgeries in a developing country 10.1136/bjo.2004.063479
Nocardia endophthalmitis after cataract surgery: clinicomicrobiological study 10.1016/j.ajo.2004.12.005
A cluster of cases of Mycobacterium chelonei keratitis following penetrating keratoplasty 10.4103/0301-4738.15292
The Madurai Intraocular Lens Study. II: Clinical outcomes 10.1016/s0002-9394(99)80230-x
The Madurai Intraocular Lens Study. I: A randomized clinical trial comparing complications and vision outcomes of intracapsular cataract extraction and extracapsular cataract extraction with posterior chamber intraocular lens 10.1016/s0002-9394(99)80229-3
Exploratory Use of Fluorescent SmartProbes for the Rapid Detection of Microbial Isolates Causing Corneal Ulcer 10.1016/j.ajo.2020.06.014
The role of fungi in fungal keratitis 10.1016/j.exer.2020.108372
Recycled femtosecond patient interface device and nasal aspirator for eye fixation in wetlab training 10.1097/j.jcrs.0000000000000328
Cross-Linking-Assisted Infection Reduction: A Randomized Clinical Trial Evaluating the Effect of Adjuvant Cross-Linking on Outcomes in Fungal Keratitis 10.1016/j.ophtha.2019.08.029
Evaluation of Metagenomic Deep Sequencing as a Diagnostic Test for Infectious Keratitis 10.1016/j.ophtha.2020.07.030
Matthew Burton
Burton Matthew
ORCID: 0000-0003-1872-9169
Prospective Study of the Diagnostic Accuracy of the In Vivo Laser Scanning Confocal Microscope for Severe Microbial Keratitis 10.1016/j.ophtha.2016.07.009
Blinding Trachoma: Systematic Review of Rates and Risk Factors for Progressive Disease 10.1371/journal.pntd.0004859
Fibroblasts profiling in scarring trachoma identifies IL-6 as a functional component of a fibroblast-macrophage pro-fibrotic and pro-inflammatory feedback loop 10.1038/srep28261
Differential frequency of NKG2C/KLRC2 deletion in distinct African populations and susceptibility to Trachoma: a new method for imputation of KLRC2 genotypes from SNP genotyping data 10.1007/s00439-016-1694-2
Altered Patterns of Fungal Keratitis at a London Ophthalmic Referral Hospital: An Eight-Year Retrospective Observational Study 10.1016/j.ajo.2016.05.021
Increased Epithelial Expression of CTGF and S100A7 with Elevated Subepithelial Expression of IL-1β in Trachomatous Trichiasis 10.1371/journal.pntd.0004752
Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial. 10.1016/s2214-109x(16)30052-3
Immunohistochemical Analysis of Scarring Trachoma Indicates Infiltration by Natural Killer and Undefined CD45 Negative Cells 10.1371/journal.pntd.0004734
Enhanced antibiotic distribution strategies and the potential impact of facial cleanliness and environmental improvements for the sustained control of trachoma: A modelling study 10.1186/s12916-016-0614-6
Impact of Trichiasis Surgery on Quality of Life: A Longitudinal Study in Ethiopia 10.1371/journal.pntd.0004627
Inverse relationship between microRNA-155 and -184 expression with increasing conjunctival inflammation during ocular Chlamydia trachomatis infection 10.1186/s12879-016-1367-8
Posterior lamellar versus bilamellar tarsal rotation surgery for trachomatous trichiasis in Ethiopia: a randomised controlled trial. 10.1016/s2214-109x(15)00299-5
Diabetic retinopathy in Tanzania: Prevalence and risk factors at entry into a regional screening programme 10.1111/tmi.12652
Diabetic retinopathy screening: experiences from northern Tanzania. 10.1016/s2213-8587(15)00422-2
Estimating the Future Impact of a Multi-Pronged Intervention Strategy on Ocular Disease Sequelae Caused by Trachoma: A Modeling Study 10.3109/09286586.2015.1081249
Conjunctival fibrosis and the innate barriers to Chlamydia trachomatis intracellular infection: A genome wide association study 10.1038/srep17447
Clinical validation of a smartphone-based adapter for optic disc imaging in Kenya 10.1001/jamaophthalmol.2015.4625
Trachoma and Relative Poverty: A Case-Control Study 10.1371/journal.pntd.0004228
The Impact of Trachomatous Trichiasis on Quality of Life: A Case Control Study 10.1371/journal.pntd.0004254
Interventions for trachoma trichiasis. 10.1002/14651858.cd004008.pub3
The Arclight Ophthalmoscope: A Reliable Low-Cost Alternative to the Standard Direct Ophthalmoscope 10.1155/2015/743263
Toluidine blue 0.05%vital staining for the diagnosis of ocular surface squamous neoplasia in Kenya 10.1001/jamaophthalmol.2015.3345
Clinical presentation of ocular surface squamous neoplasia in Kenya 10.1001/jamaophthalmol.2015.3335
Development and validation of a smartphone-based visual acuity test (peek acuity) for clinical practice and Community-Based Fieldwork 10.1001/jamaophthalmol.2015.1468
Pathogenesis of Progressive Scarring Trachoma in Ethiopia and Tanzania and Its Implications for Disease Control: Two Cohort Studies 10.1371/journal.pntd.0003763
Planning eye health services in Varamin district, Iran: A cross-sectional study 10.1186/s12913-015-0797-0
Epilation for Minor Trachomatous Trichiasis: Four-Year Results of a Randomised Controlled Trial 10.1371/journal.pntd.0003558
The conjunctival microbiome in health and trachomatous disease: A case control study 10.1186/s13073-014-0099-x
Pathophysiology of ocular surface squamous neoplasia 10.1016/j.exer.2014.10.015
The Nakuru eye disease cohort study: methodology & rationale. 10.1186/1471-2415-14-60
Ocular rhinosporidiosis mimicking conjunctival squamous papilloma in Kenya - A case report 10.1186/1471-2415-14-45
Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3 10.1371/journal.pntd.0002744
Posterior segment eye disease in sub-Saharan Africa: Review of recent population-based studies 10.1111/tmi.12276
A smartphone based ophthalmoscope. 10.1109/embc.2014.6944049
Diagnosing ocular surface squamous neoplasia in east africa: Case-control study of clinical and in vivo confocal microscopy assessment 10.1016/j.ophtha.2013.09.027
Cataract surgery in Southern Ethiopia: Distribution, rates and determinants of service provision 10.1186/1472-6963-13-480
Epidemiology of ocular surface squamous neoplasia in Africa 10.1111/tmi.12203
The Outcome of Trachomatous Trichiasis Surgery in Ethiopia: Risk Factors for Recurrence 10.1371/journal.pntd.0002392
In vivo confocal microscopy and histopathology of the conjunctiva in trachomatous scarring and normal tissue: A systematic comparison 10.1136/bjophthalmol-2013-303126
Doxycycline prevents matrix remodeling and contraction by trichiasis-derived conjunctival fibroblasts 10.1167/iovs.13-11787
Using a Nonparametric Multilevel Latent Markov Model to Evaluate Diagnostics for Trachoma 10.1093/aje/kws345
Conjunctival MicroRNA Expression in Inflammatory Trachomatous Scarring 10.1371/journal.pntd.0002117
Trachoma: Protective and Pathogenic Ocular Immune Responses to Chlamydia trachomatis 10.1371/journal.pntd.0002020
Eyescores: An open platform for secure electronic data and photographic evidence collection in ophthalmological field studies 10.1136/bjophthalmol-2012-302653
Post-Operative Recurrent Trachomatous Trichiasis Is Associated with Increased Conjunctival Expression of S100A7 (Psoriasin) 10.1371/journal.pntd.0001985
Why Do People Not Attend for Treatment for Trachomatous Trichiasis in Ethiopia? A Study of Barriers to Surgery 10.1371/journal.pntd.0001766
Epilepsy in Tanzanian children: Association with perinatal events and other risk factors 10.1111/j.1528-1167.2011.03395.x
Trachomatous Trichiasis and its Management in Endemic Countries 10.1016/j.survophthal.2011.08.002
Absorbable versus silk sutures for surgical treatment of trachomatous trichiasis in Ethiopia: A randomised controlled trial 10.1371/journal.pmed.1001137
Surgery versus epilation for the treatment of minor trichiasis in Ethiopia: A randomised controlled noninferiority trial 10.1371/journal.pmed.1001136
Behavioural comorbidity in Tanzanian children with epilepsy: A community-based case-control study 10.1111/j.1469-8749.2011.04109.x
Co-morbidity of epilepsy in Tanzanian children: A community-based case-control study 10.1016/j.seizure.2011.10.011
Innate immune responses and modified extracellular matrix regulation characterize bacterial infection and cellular/connective tissue changes in scarring trachoma. 10.1128/iai.05965-11
The clinical phenotype of trachomatous trichiais in Ethiopia: Not all trichiasis is due to Entropion 10.1167/iovs.11-7880
Epilation for trachomatous trichiasis and the risk of corneal opacification 10.1016/j.ophtha.2011.06.045
In vivo confocal microscopy in scarring trachoma 10.1016/j.ophtha.2011.04.014
Active trachoma is associated with increased conjunctival expression of IL17A and profibrotic cytokines. 10.1128/iai.05718-11
Microbial keratitis in East Africa: why are the outcomes so poor? 10.3109/09286586.2011.595041
What Is causing active trachoma? The role of nonchlamydial bacterial pathogens in a low prevalence setting 10.1167/iovs.11-7326
Bacterial infection in scarring trachoma 10.1167/iovs.10-5829
Clearing the backlog: Trichiasis surgeon retention and productivity in Northern Ethiopia 10.1371/journal.pntd.0001014
In vivo confocal microscopy of trachoma in relation to normal tarsal conjunctiva 10.1016/j.ophtha.2010.08.029
Targeting antibiotics to households for trachoma control 10.1371/journal.pntd.0000862
Conjunctival transcriptome in scarring trachoma. 10.1128/iai.00888-10
Profound and sustained reduction in Chlamydia trachomatis in The Gambia: A five-year longitudinal study of trachoma endemic communities 10.1371/journal.pntd.0000835
Quality assurance in trichiasis surgery: A methodology 10.1136/bjo.2010.186197
Human conjunctival transcriptome analysis reveals the prominence of innate defense in Chlamydia trachomatis infection. 10.1128/iai.00844-10
Trichiasis surgery in the gambia: A 4-year prospective study 10.1167/iovs.10-5169
Epidemiology and control of trachoma: Systematic review 10.1111/j.1365-3156.2010.02521.x
Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery 10.1167/iovs.09-4550
Innate immunity in ocular Chlamydia trachomatis infection: Contribution of IL8 and CSF2 gene variants to risk of trachomatous scarring in Gambians 10.1186/1471-2350-10-138
The global burden of trachoma: A review 10.1371/journal.pntd.0000460
When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries 10.1371/journal.pntd.0000458
Estimating household and community transmission of ocular Chlamydia trachomatis 10.1371/journal.pntd.0000401
Chlamydia trachomatis ompA variants in trachoma: what do they tell us? 10.1371/journal.pntd.0000306
Bacterial infection and trachoma in the Gambia: A case-control study 10.1167/iovs.07-0315
Trachoma: An overview 10.1093/bmb/ldm034
Chlamydial positivity of nasal discharge at baseline is associated with ocular chlamydial positivity 2 months following azithromycin treatment 10.1167/iovs.05-1599
The SAFE strategy for trachoma control: Using operational research for policy, planning and implementation. 10.2471/blt.05.28696
A coding polymorphism in matrix metalloproteinase 9 reduces risk of scarring sequelae of ocular Chlamydia trachomatis infection 10.1186/1471-2350-7-40
The long-term natural history of trachomatous trichiasis in The Gambia 10.1167/iovs.05-0714
Conjunctival chlamydial 16S ribosomal RNA expression in trachoma: is chlamydial metabolic activity required for disease to develop? 10.1086/499814
A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia 10.1136/bjo.2004.062489
Long term outcome of trichiasis surgery in the Gambia 10.1136/bjo.2004.055996
Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. 10.1016/s0140-6736(05)61029-x
Cytokine and fibrogenic gene expression in the conjunctivas of subjects from a Gambian community where trachoma is endemic. 10.1128/iai.72.12.7352-7356.2004
Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages 10.1167/iovs.03-0107
Strategies for control of trachoma: observational study with quantitative PCR. 10.1016/s0140-6736(03)13909-8
Plummeting lenses in the TB clinic. 10.1016/s0140-6736(02)09415-1
Selective hypertrophy of the cauda equina nerve roots 10.1007/s004150200014
Azithromycin for the treatment and control of trachoma 10.1517/14656566.3.2.113
Jejunal intussusception secondary to Peutz--Jeghers type hamartoma diagnosed on angiography. 10.1016/s0009-9260(99)90837-1
The prevalence of cataract in two villages of northern Pakistan with different levels of ultraviolet radiation 10.1038/eye.1997.19
Towards a safe and effective chlamydial vaccine: Lessons from the eye 10.1016/j.vaccine.2013.10.016
Pathway-focused arrays reveal increased matrix metalloproteinase-7 (Matrilysin) transcription in trachomatous trichiasis 10.1167/iovs.09-5054
The development of an age-structured model for trachoma transmission dynamics, pathogenesis and control 10.1371/journal.pntd.0000462
Interventions for trachoma trichiasis. 10.1002/14651858.cd004008.pub2
Risk of trachomatous scarring and trichiasis in Gambians varies with SNP haplotypes at the interferon-gamma and interleukin-10 loci 10.1038/sj.gene.6364182
Antibiotic dosage in trachoma control programs: Height as a surrogate for weight in children 10.1167/iovs.02-0234
In vivo confocal microscopy appearance of Fusarium and Aspergillus species in fungal keratitis 10.1136/bjophthalmol-2016-309656
Six-year incidence of blindness and visual impairment in Kenya: The Nakuru eye disease cohort study 10.1167/iovs.16-19835
The Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic Treatment 10.1371/journal.pntd.0005080
Risk factors for ocular surface squamous neoplasia in Kenya: a case–control study 10.1111/tmi.12792
Prevalence, risk factors, and complications of diabetes in the Kilimanjaro region: A population-based study from Tanzania 10.1371/journal.pone.0164428
Defining Ocular Surface Disease Activity and Damage Indices by an International Delphi Consultation 10.1016/j.jtos.2016.08.005
Impact of trichiasis surgery on daily living: A longitudinal study in Ethiopia 10.12688/wellcomeopenres.11891.1
Immunofibrogenic gene expression patterns in Tanzanian children with ocular Chlamydia trachomatis Infection, active trachoma and scarring: Baseline results of a 4-year longitudinal study 10.3389/fcimb.2017.00406
Delay along the care-seeking journey of patients with ocular surface squamous neoplasia in Kenya 10.1186/s12913-017-2428-4
Diabetes in sub-Saharan Africa: from clinical care to health policy. 10.1016/s2213-8587(17)30181-x
What are the priorities for improving cataract surgical outcomes in Africa? Results of a Delphi exercise 10.1007/s10792-017-0599-y
Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansion 10.1101/gr.212647.116
Six-year incidence and progression of age-related macular degeneration in Kenya nakuru eye disease cohort study 10.1001/jamaophthalmol.2017.1109
Persistence of innate immune pathways in late stage human bacterial and fungal keratitis: results from a comparative transcriptome analysis 10.3389/fcimb.2017.00193
Reduced-cost Chlamydia trachomatis-specific multiplex real-time PCR diagnostic assay evaluated for ocular swabs and use by trachoma research programmes 10.1016/j.mimet.2017.04.010
Predictors of Trachomatous Trichiasis Surgery Outcome 10.1016/j.ophtha.2017.03.016
The incidence of diabetes mellitus and diabetic retinopathy in a population-based cohort study of people age 50 years and over in Nakuru, Kenya 10.1186/s12902-017-0170-x
miRNAs that associate with conjunctival inflammation and ocular Chlamydia trachomatis infection do not predict progressive disease 10.1093/femspd/ftx016
Impact of trichiasis surgery on daily living: A longitudinal study in Ethiopia 10.12688/wellcomeopenres.11891.2
Epidemiology, risk factors, and clinical outcomes in severe microbial keratitis in South India 10.1080/09286586.2018.1454964
Reference values for body composition and associations with blood pressure in Kenyan adults aged ≥50 years old 10.1038/s41430-018-0177-z
Oral doxycycline for the prevention of postoperative trachomatous trichiasis in Ethiopia: a randomised, double-blind, placebo-controlled trial. 10.1016/s2214-109x(18)30111-6
Glaucoma Features in an East African Population: A 6-Year Cohort Study of Older Adults in Nakuru, Kenya. 10.1097/ijg.0000000000000941
In Vivo Confocal Microscopy Cellular Features of Host and Organism in Bacterial, Fungal, and Acanthamoeba Keratitis 10.1016/j.ajo.2018.03.010
Evaluation of a Chlamydia trachomatis-specific, commercial, real-time PCR for use with ocular swabs 10.1186/s13071-018-2686-y
The impact of glaucoma on quality of life in Ethiopia: A case-control study 10.1186/s12886-017-0643-8
Rapid assessment of avoidable blindness for health service planning 10.2471/BLT.18.217794
Smartphone-based screening for visual impairment in Kenyan school children: a cluster randomised controlled trial 10.1016/S2214-109X(18)30244-4
Antarctica eye study: A prospective study of the effects of overwintering on ocular parameters and visual function 10.1186/s12886-018-0816-0
Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis 10.12688/wellcomeopenres.13423.2
Bilateral Candida keratitis in an HIV patient with asymptomatic genitourinary candidiasis in Uganda 10.1016/j.mmcr.2018.07.007
Evaluation of a Chlamydia trachomatis-specific, commercial, real-time PCR for use with ocular swabs 10.1101/245605
Age-specific prevalence of anti-Pgp3 antibodies and severe conjunctival scarring in the Solomon Islands 10.1101/141135
Delay Along the Care Seeking Journey of Patients with Microbial Keratitis in Uganda 10.1080/09286586.2019.1616775
Traditional eye medicine use in microbial keratitis in uganda: A mixed methods study 10.12688/wellcomeopenres.15259.2
Vascular occlusive disease 10.1007/978-3-540-29542-6_21
3D images as a field grader training tool for trachomatous trichiasis: A diagnostic accuracy study in Ethiopia 10.1371/journal.pntd.0007104
Non-chlamydial bacterial infection and progression of conjunctival scarring in trachoma 10.1167/iovs.17-23381
Horizon Europe: towards a European agenda for global health research and innovation 10.1016/S0140-6736(19)30287-9
Mortality during 6 years of follow-up in relation to visual impairment and eye disease: Results from a population-based cohort study of people aged 50 years and above in Nakuru, Kenya 10.1136/bmjopen-2019-029700
Retinopathy in Gambian Children Admitted to Hospital with Malaria 10.1177/004947550403400409
Impact of trichiasis surgery on daily living: A longitudinal study in Ethiopia [version 2; referees: 2 approved] 10.12688/wellcomeopenres.11891
Clinical signs of trachoma are prevalent among Solomon Islanders who have no persistent markers of prior infection with Chlamydia trachomatis [version 1; referees: 2 approved] 10.12688/wellcomeopenres.13423.1
Cellular morphological changes detected by laser scanning in vivo confocal microscopy associated with clinical outcome in fungal keratitis 10.1038/s41598-019-44833-9
The conjunctival transcriptome in Ethiopians after trichiasis surgery: associations with the development of eyelid contour abnormalities and the effect of oral doxycycline treatment 10.12688/wellcomeopenres.15419.1
Severity of Visual Field Loss at First Presentation to Glaucoma Clinics in England and Tanzania 10.1080/09286586.2019.1661499
The management of microbial keratitis within Uganda’s primary health system: a situational analysis 10.12688/wellcomeopenres.15463.1
Risk Factors of Microbial Keratitis in Uganda: A Case Control Study 10.1080/09286586.2019.1682619
Survey of ophthalmologists-in-training in Eastern, Central and Southern Africa: A regional focus on ophthalmic surgical education 10.12688/wellcomeopenres.15580.1
Smartphone-Guided Algorithms for Use by Community Volunteers to Screen and Refer People With Eye Problems in Trans Nzoia County, Kenya: Development and Validation Study 10.2196/16345
Smartphone-Guided Algorithms for Use by Community Volunteers to Screen and Refer People With Eye Problems in Trans Nzoia County, Kenya: Development and Validation Study (Preprint) 10.2196/preprints.16345
Primary Eye Care in Eastern Nepal 10.1080/09286586.2019.1702217
Effective refractive error coverage: an eye health indicator to measure progress towards universal health coverage 10.1111/opo.12662
Rationale and feasibility of a combined rapid assessment of avoidable blindness and hearing loss protocol 10.1371/journal.pone.0229008
Interventions to promote access to eye care for non-Indigenous, non-dominant ethnic groups in high-income countries: a scoping review protocol 10.1136/bmjopen-2019-033775
Action needed to improve equity and diversity in global eye health leadership 10.1038/s41433-020-0843-y
Ocular Chlamydia trachomatis infection, anti-Pgp3 antibodies and conjunctival scarring in Vanuatu and Tarawa, Kiribati before antibiotic treatment for trachoma 10.1016/j.jinf.2020.01.015
Rapid Assessment of Avoidable Blindness: Looking back, looking forward 10.1136/bjophthalmol-2019-314015
Selecting behaviour change priorities for trachoma ‘F’ and ‘E’ interventions: A formative research study in Oromia, Ethiopia 10.1371/journal.pntd.0007784
Ophthalmic Simulated Surgical Competency Assessment Rubric for manual small-incision cataract surgery 10.1016/j.jcrs.2019.04.010
Conjunctival Microbiome-Host Responses Are Associated With Impaired Epithelial Cell Health in Both Early and Late Stages of Trachoma 10.3389/fcimb.2019.00297
Global eye health and the sustainable development goals: Protocol for a scoping review 10.1136/bmjopen-2019-035789
In Vitro Topical Delivery of Chlorhexidine to the Cornea: Enhancement Using Drug-Loaded Contact Lenses and β-Cyclodextrin Complexation, and the Importance of Simulating Tear Irrigation 10.1021/acs.molpharmaceut.0c00140
Understanding hard-to-reach communities: Local perspectives and experiences of trachoma control among the pastoralist Maasai in northern Tanzania 10.1017/S0021932020000553
Validation of handheld fundus camera with mydriasis for retinal imaging of diabetic retinopathy screening in China: A prospective comparison study 10.1136/bmjopen-2020-040196
Intense Simulation-Based Surgical Education for Manual Small-Incision Cataract Surgery: The Ophthalmic Learning and Improvement Initiative in Cataract Surgery Randomized Clinical Trial in Kenya, Tanzania, Uganda, and Zimbabwe 10.1001/jamaophthalmol.2020.4718
Knowledge, perceptions and experiences of trachoma among Maasai in Tanzania: Implications for prevention and control 10.1371/journal.pntd.0007508
Progression of scarring trachoma in Tanzanian children: A four-year cohort study 10.1371/journal.pntd.0007638
Ophthalmic simulated surgical competency assessment rubric (Sim-OSSCAR) for trabeculectomy 10.1136/bmjophth-2019-000313
Presentation, surgery and 1-year outcomes of childhood cataract surgery in Tanzania 10.1136/bjophthalmol-2020-316042
Pre-operative trichiatic eyelash pattern predicts post-operative trachomatous trichiasis 10.1371/journal.pntd.0007637
Ocular immune responses, Chlamydia trachomatis infection and clinical signs of trachoma before and after azithromycin mass drug administration in a treatment naïve trachoma-endemic Tanzanian community 10.1371/journal.pntd.0007559
Viability PCR shows that non-ocular surfaces could contribute to transmission of chlamydia trachomatis infection in trachoma 10.1371/journal.pntd.0008449
Epidemiology of Microbial Keratitis in Uganda: A Cohort Study 10.1080/09286586.2019.1700533
The impact of microbial keratitis on quality of life in Uganda 10.1136/bmjophth-2019-000351
Detecting extra-ocular chlamydia trachomatis in a trachoma-endemic community in ethiopia: Identifying potential routes of transmission 10.1371/journal.pntd.0008120
The inverse-research law of eye health 10.1038/s41433-019-0528-6
The global incidence and diagnosis of fungal keratitis 10.1016/S1473-3099(20)30448-5
Posterior lamellar versus bilamellar tarsal rotation surgery for trachomatous trichiasis: Long-term outcomes from a randomised controlled trial 10.1016/j.eclinm.2019.10.015
Response to: Comment on: ‘The inverse-research law of global eye health’ 10.1038/s41433-020-0808-1
Responses of the putative trachoma vector, musca sorbens, to volatile semiochemicals from human faeces 10.1371/journal.pntd.0007719
Peek Community Eye Health - MHealth system to increase access and efficiency of eye health services in Trans Nzoia County, Kenya: Study protocol for a cluster randomised controlled trial 10.1186/s13063-019-3615-x
Infectious corneal ulceration: A proposal for neglected tropical disease status 10.2471/BLT.19.232660
Are we advancing universal health coverage through cataract services? Protocol for a scoping review 10.1136/bmjopen-2020-039458
Association between vision impairment and mortality: Protocol for a systematic review and meta-analysis 10.1136/bmjopen-2020-037556
Utilization of secondary eye care services in western Kenya 10.3390/ijerph16183371
Immunopathogenesis of progressive scarring trachoma: Results of a 4-year longitudinal study in Tanzanian children 10.1128/IAI.00629-19
Announcing The Lancet Global Health Commission on Global Eye Health 10.1016/S2214-109X(19)30450-4
Development and validation of a smartphone-based contrast sensitivity test 10.1167/tvst.8.5.13
Eye health and quality of life: An umbrella review protocol 10.1136/bmjopen-2020-037648
In vivo confocal microscopy and trachomatous conjunctival scarring: Predictors for clinical progression 10.1111/ceo.13843
Comparison of face washing and face wiping methods for trachoma control: A pilot study 10.4269/ajtmh.19-0726
Associations between vision impairment and driving and the effectiveness of vision-related interventions: Protocol for a systematic review and meta-analysis 10.1136/bmjopen-2020-040881
Incidence of Visually Impairing Cataracts among Older Adults in Kenya 10.1001/jamanetworkopen.2019.6354
In vitro activity of chlorhexidine compared with seven antifungal agents against 98 Fusarium isolates recovered from fungal keratitis patients 10.1128/AAC.02669-18
DjinniChip: evaluation of a novel molecular rapid diagnostic device for the detection of Chlamydia trachomatis in trachoma-endemic areas 10.1186/s13071-020-04414-6
The Gambia National Eye Health Survey 2019: survey protocol 10.12688/wellcomeopenres.16531.1
Eye care delivery models to improve access to eye care for Indigenous peoples in high-income countries: a scoping review 10.1136/bmjgh-2020-004484
Mycotic Keratitis—A Global Threat from the Filamentous Fungi 10.3390/jof7040273
Experiences and Perceptions of Ophthalmic Simulation-Based Surgical Education in Sub-Saharan Africa. 10.1016/j.jsurg.2021.04.005
Global economic productivity losses from vision impairment and blindness 10.1016/j.eclinm.2021.100852
Lag Time between Onset of First Symptom and Treatment of Retinoblastoma: An International Collaborative Study of 692 Patients from 10 Countries. 10.3390/cancers13081956
Eye health indicators for universal health coverage: results of a global expert prioritisation process. 10.1136/bjophthalmol-2020-318481
Gender and ethnic diversity in global ophthalmology and optometry association leadership: a time for change. 10.1111/opo.12793
The Lancet Global Health Commission on Global Eye Health: vision beyond 2020. 10.1016/s2214-109x(20)30488-5
Association between vision impairment and mortality: a systematic review and meta-analysis. 10.1016/s2214-109x(20)30549-0
A Global Assessment of Eye Health and Quality of Life: A Systematic Review of Systematic Reviews. 10.1001/jamaophthalmol.2021.0146
Simulation-based surgical education for glaucoma versus conventional training alone: the GLAucoma Simulated Surgery (GLASS) trial. A multicentre, multicountry, randomised controlled, investigator-masked educational intervention efficacy trial in Kenya, South Africa, Tanzania, Uganda and Zimbabwe. 10.1136/bjophthalmol-2020-318049
Effectiveness of interventions to increase uptake and completion of treatment for diabetic retinopathy in low- and middle-income countries: a rapid review protocol. 10.1186/s13643-020-01562-9
Effectiveness of task-shifting for the detection of diabetic retinopathy in low- and middle-income countries: a rapid review protocol. 10.1186/s13643-020-01553-w
Ophthalmology training in sub-Saharan Africa: a scoping review. 10.1038/s41433-020-01335-7
Effect of repeated epilation for minor trachomatous trichiasis on lash burden, phenotype and surgical management willingness: A cohort study. 10.1371/journal.pntd.0008882
A global review of publicly available datasets for ophthalmological imaging: barriers to access, usability, and generalisability. 10.1016/s2589-7500(20)30240-5
Topical chlorhexidine 0.2% versus topical natamycin 5% for fungal keratitis in Nepal: rationale and design of a randomised controlled non-inferiority trial. 10.1136/bmjopen-2020-038066
Estimating the global cost of vision impairment and its major causes: protocol for a systematic review. 10.1136/bmjopen-2019-036689
Interventions to improve the quality of cataract services: protocol for a global scoping review. 10.1136/bmjopen-2019-036413
Red reflex examination in reproductive and child health clinics for early detection of paediatric cataract and ocular media disorders: cross-sectional diagnostic accuracy and feasibility studies from Kilimanjaro, Tanzania. 10.1038/s41433-020-1019-5
Targeted treatment of active trachoma. 10.1001/jama.297.6.588-a
Traditional eye medicine use in microbial keratitis in Uganda: a mixed methods study 10.12688/wellcomeopenres.15259.1
Characterization of a descending system that enables crossed group II inhibitory reflex pathways in the cat spinal cord 10.1523/jneurosci.16-02-00723.1996
Chlamydial Infections 10.1016/B978-1-4160-4390-4.00048-5
Strategies for control of trachoma: observational study with quantitative PCR11Lancet 2003;362:198–204. 10.1016/j.ajo.2003.08.028
Retinopathy in Gambian children admitted to hospital with malaria 10.1016/S0035-9203(03)80064-0
Estimating Need for Glasses and Hearing Aids in The Gambia: Results from a National Survey and Comparison of Clinical Impairment and Self-Report Assessment Approaches 10.3390/ijerph18126302
Visual function rather than visual acuity - Authors' reply. 10.1016/s2214-109x(21)00246-1
Effectiveness of an mHealth system on access to eye health services in Kenya: a cluster-randomised controlled trial. 10.1016/S2589-7500(21)00083-2
Keeping an eye on eye care: monitoring progress towards effective coverage. 10.1016/s2214-109x(21)00212-6
Towards an odour-baited trap to control Musca sorbens, the putative vector of trachoma. 10.1038/s41598-021-91609-1
Knowledge and awareness-based survey of COVID-19 within the eye care profession in Nepal: Misinformation is hiding the truth 10.1371/journal.pone.0254761
Chlorhexidine gluconate 0.2% as a treatment for recalcitrant fungal keratitis in Uganda: a pilot study. 10.1136/bmjophth-2020-000698
How can we improve the quality of cataract services for all? A global scoping review. 10.1111/ceo.13976
Sex, gender, and retinoblastoma: analysis of 4351 patients from 153 countries. 10.1038/s41433-021-01675-y
Interventions to promote access to eyecare for non-dominant ethnic groups in high-income countries: a scoping review 10.1136/bmjgh-2021-006188
Fiona Stapleton
Stapleton Fiona
ORCID: 0000-0002-7203-5443
Microbiology, lens care and maintenance 10.1016/B978-0-7020-7168-3.00004-0
Differences in Tear Film Biochemistry of Symptomatic and Asymptomatic Lens Wearers 10.1097/OPX.0000000000001110
Biocidal efficacy of silver-impregnated contact lens storage cases in vitro 10.1167/iovs.09-4809
Long-term Effects of LASIK on Corneal Innervation and Tear Neuropeptides and the Associations With Dry Eye 10.3928/1081597X-20160603-01
An evidence-based brochure to educate contact lens wearers about safe contact lens wear 10.1111/j.1444-0938.2009.00398.x
Bacterial coaggregation among the most commonly isolated bacteria from contact lens cases 10.1167/iovs.16-20593
Clinical and biochemical tear lipid parameters in contact lens wearers 10.1097/OPX.0000000000000420
Antibiotic resistance characteristics of pseudomonas aeruginosa isolated from keratitis in Australia and India 10.3390/antibiotics9090600
Corneal and conjunctival sensitivity in intolerant contact lens wearers 10.1016/j.optom.2014.05.004
Acquired fluoroquinolone resistance genes in corneal isolates of Pseudomonas aeruginosa 10.1016/j.meegid.2020.104574
Patient perspectives of cataract surgery: protocol and baseline findings of a cohort study 10.1111/cxo.12686
Characteristics of and risk factors for contact lens-related microbial keratitis in a tertiary referral hospital 10.1038/sj.eye.6702953
Bacterial coaggregation and cohesion among isolates from contact lens cases 10.1167/iovs.17-23155
The international workshop on meibomian gland dysfunction: Report of the clinical trials subcommittee 10.1167/iovs.10-6997h
Management of Symptomatic Meesmann Dystrophy 10.1097/OPX.0b013e3181baad27
Pilot study of contact lens practitioner risk-taking propensity 10.1097/OPX.0b013e31821ddd9c
iCareTrack: measuring the appropriateness of eyecare delivery in Australia 10.1111/opo.12699
Association study of single nucleotide polymorphisms in IL-10 and IL-17 genes with the severity of microbial keratitis 10.1016/j.clae.2019.06.007
Dry eye signs and symptoms in aromatase inhibitor treatment and the relationship with pain 10.1016/j.jtos.2019.10.008
Reproducibility of and Effect of Magnification on Optical Coherence Tomography Measurements in Children 10.1016/j.ajo.2006.11.042
In vitro antimicrobial efficacy of silver lens cases used with a multipurpose disinfecting solution 10.1167/tvst.8.3.52
Impact of contact lens material, design, and fitting on discomfort 10.1097/ICL.0000000000000318
Influence of tear film and contact lens osmolality on ocular comfort in contact lens wear 10.1097/OPX.0b013e3181ae027b
The Lanindar test: A method of evaluating patient suitability for cataract surgery using assisted topical anaesthesia 10.1038/sj.eye.6703080
Contact lens-related corneal infection in Australia 10.1111/cxo.13082
A review of cosmetic contact lens infections 10.1038/s41433-018-0257-2
4. Contemporary research in contact lens care 10.1016/S1367-0484(13)60006-5
Risk factors for physical discomfort in Australian optometrists 10.1097/OPX.0b013e3182045a8e
Comparison of tear lipid profile among basal, reflex, and flush tear samples 10.1097/OPX.0000000000000411
Development of a Chinese version of the ocular comfort index 10.1167/iovs.14-14276
Outcome of keratoconus management: Review of the Past 20 Years' contemporary treatment modalities 10.1097/ICL.0000000000000270
Density and Morphology of Corneal Epithelial Dendritic Cells are Different in Allergy 10.1080/02713683.2019.1695845
Corneal nerve morphology, sensitivity, and tear neuropeptides in contact lens wear 10.1097/OPX.0000000000001063
Effect of a formulated eye drop with Leptospermum spp honey on tear film properties 10.1136/bjophthalmol-2019-315160
The epidemiology of microbial keratitis with silicone hydrogel contact lenses 10.1097/ICL.0b013e3182713919
Macular thickness, retinal thickness, and optic disk parameters in dominant compared with nondominant eyes 10.1016/j.jaapos.2008.11.004
Removal of biofilm from contact lens storage cases 10.1167/iovs.10-5796
The role of corneal innervation in lasik-induced neuropathic dry eye 10.1016/j.jtos.2013.09.001
Health- and vision-related quality of life in intellectually disabled children 10.1097/OPX.0b013e3181c1d533
Infection control guidelines for optometrists 2016 10.1111/cxo.12544
Bovine lactoferrin stimulates human corneal epithelial alkali wound healing in vitro 10.1167/iovs.08-1882
Risk factors and causative organisms in microbial keratitis 10.1097/ICO.0b013e318156caf2
Alteration of the pattern of regenerative corneal subbasal nerves after laser in-situ keratomileusis surgery 10.1111/opo.12723
Contact lens and lens storage case cleaning instructions: Whose advice should we follow? 10.1097/ICL.0b013e3181cf8aff
Risk factors for contact lens-related microbial keratitis in Singapore 10.1038/eye.2015.250
Contact lens-induced discomfort and protein changes in tears 10.1097/OPX.0000000000000888
Factors affecting the morbidity of contact lens-related microbial keratids: A population study 10.1167/iovs.06-0564
Effect of low-dose atropine on myopia progression, pupil diameter and accommodative amplitude: Low-dose atropine and myopia progression 10.1136/bjophthalmol-2019-315440
High-Dose Steroid Treatment of Bacterial Keratitis 10.1097/ICO.0000000000001794
The effect of long-term wear of soft lenses of low and high oxygen transmissibility on the corneal epithelium 10.1038/eye.2008.307
Bovine lactoferrin promotes corneal wound healing and suppresses IL-1 expression in alkali wounded mouse cornea 10.3109/02713683.2013.811259
Perspective on 15 years of research: Reduced risk of microbial keratitis with frequent-replacement contact lenses 10.1097/01.icl.0000248157.94115.7c
Surveillance of contact lens related microbial keratitis in Australia and New Zealand: Multi-source case-capture and cost-effectiveness 10.1080/01658100701473705
Impact of lens case hygiene guidelines on contact lens case contamination 10.1097/OPX.0b013e3182282f28
Infectious corneal ulceration: A proposal for neglected tropical disease status 10.2471/BLT.19.232660
Water Exposure and the Risk of Contact Lens-Related Disease 10.1097/ICO.0000000000001898
Silicone hydrogel lens-solution interaction and inflammation 10.1097/ICL.0b013e31827d4ba1
Variables affecting refractive outcome following LASIK for myopia 10.1038/sj.eye.6702856
Changes in tear cytokine concentrations following discontinuation of soft contact lenses-a pilot study 10.1097/ICL.0000000000000182
Strategies for the prevention of contact lens-related Acanthamoeba keratitis: A review 10.1111/opo.12271
The diagnosis and management of contact lens-related microbial keratitis 10.1111/cxo.12581
Does endogenous serum oestrogen play a role in meibomian gland dysfunction in postmenopausal women with dry eye? 10.1136/bjophthalmol-2016-308473
Personal consequences of work-related physical discomfort: An exploratory study 10.1111/cxo.12066
Imaging of tear film lipids using quantum dots 10.1364/3D.2018.JW4A.18
Are cataract surgery referrals to public hospitals in Australia poorly targeted? 10.1111/ceo.13057
Daily fluctuations in ocular surface symptoms during the normal menstrual cycle and with the use of oral contraceptives 10.1016/j.jtos.2019.06.005
Contact lens-related microbial keratitis: How have epidemiology and genetics helped us with pathogenesis and prophylaxis 10.1038/eye.2011.288
Lipid Supplements and Clinical Aspects of Tear Film in Habitual Lens Wearers 10.1097/OPX.0000000000000996
Silicone hydrogel contact lenses versus hydrogel daily wear contact lenses for the correction of simple refractive error 10.1002/14651858.CD009320.pub2
Erratum: The effect of contact lens hygiene behavior on lens case contamination(Optom Vis Sci (2015) 92(167-174)) 10.1097/OPX.0000000000000634
Falls in Older people with Cataract, a longitudinal evaluation of impact and risk: The focus study protocol 10.1136/injuryprev-2013-041124
Impact of air-drying lens cases in various locations and positions 10.1097/OPX.0b013e3181e172a1
Systematic review of the appropriateness of eye care delivery in eye care practice 10.1186/s12913-019-4493-3
TFOS DEWS II Epidemiology Report 10.1016/j.jtos.2017.05.003
Ocular surface sensitivity repeatability with Cochet-Bonnet esthesiometer 10.1097/OPX.0000000000000472
Potential role of ocular microbiome, host genotype, tear cytokines, and environmental factors in corneal infiltrative events in contact lens wearers 10.1167/iovs.18-24845
TFOS DEWS II Introduction 10.1016/j.jtos.2017.05.005
Queensland Microbial Keratitis Database: 2005-2015 10.1136/bjophthalmol-2018-312881
Corneal and conjunctival sensory function: The impact on ocular surface sensitivity of change from low to high oxygen transmissibility contact lenses 10.1167/iovs.11-8416
Susceptibility of contact lens-related pseudomonas aeruginosa keratitis isolates to multipurpose disinfecting solutions, disinfectants, and antibiotics 10.1167/tvst.9.5.2
Relationship Between Climate, Disease Severity, and Causative Organism for Contact Lens-Associated Microbial Keratitis in Australia 10.1016/j.ajo.2007.06.037
TFOS DEWS II pain and sensation report 10.1016/j.jtos.2017.05.002
The effect of contact lens hygiene behavior on lens case contamination 10.1097/OPX.0000000000000477
Contact lens user profile, attitudes and level of compliance to lens care 10.1016/j.clae.2010.02.002
Contact Lens-Related Acanthamoeba Keratitis 10.1097/OPX.0b013e3181baae11
The Incidence of Contact Lens-Related Microbial Keratitis in Australia 10.1016/j.ophtha.2008.04.002
Tear lipid layer and contact lens comfort: A review 10.1097/ICL.0b013e31828af164
Pathogenesis of contact lens-associated microbial keratitis 10.1097/OPX.0b013e3181eedde2
TFOS DEWS II Definition and Classification Report 10.1016/j.jtos.2017.05.008
Development and validation of the 21-item Children's Vision for Living Scale (CVLS) by Rasch analysis 10.1111/cxo.12055
TFOS DEWS II Clinical Trial Design Report 10.1016/j.jtos.2017.05.009
The effectiveness of various cleaning regimens and current guidelines in contact lens case biofilm removal 10.1167/iovs.10-6785
Residual corneal flattening after discontinuation of long-term orthokeratology lens wear in asian children 10.1097/ICL.0b013e3181bdc41f
Interactions of contact lenses with multipurpose disinfecting solution containing PHMB 10.1097/ICL.0000000000000047
Understanding the stimulus of an air-jet aesthesiometer: Computerised modelling and subjective interpretation 10.1111/opo.12025
The risk of vision loss in contact lens wear and following LASIK 10.1111/opo.12663
Application of clinical techniques relevant for glaucoma assessment by optometrists: Concordance with guidelines 10.1111/opo.12146
Epidemiology of contact lens-related inflammation and microbial keratitis: A 20-year perspective 10.1097/ICL.0b013e318157c49d
Prevalence of myopia among disadvantaged Australian schoolchildren: A 5-year cross-sectional study 10.1371/journal.pone.0238122
Contact lens hygiene compliance and lens case contamination: A review 10.1016/j.clae.2015.04.007
Conjunctival muc5ac+ goblet cell index: Relationship with corneal nerves and dry eye 10.1007/s00417-018-4065-y
Visual and refractive associations with falls after first-eye cataract surgery 10.1016/j.jcrs.2017.07.029
3. Ocular surface health with contact lens wear 10.1016/S1367-0484(13)60005-3
Prospective Controlled Study of Vapor Pressure Tear Osmolality and Tear Meniscus Height in Nasolacrimal Duct Obstruction 10.1016/j.ajo.2005.12.051
The TFOS International Workshop on Contact Lens Discomfort: Report of the subcommittee on neurobiology 10.1167/iovs.13-13226
Erratum: Differences in tear film biochemistry of symptomatic and asymptomatic lens wearers (Optometry and Vision Science (2017) 94 (914-918) DOI: 10.1097/OPX.0000000000001110) 10.1097/OPX.0000000000001314
Method development for quantification of five tear proteins using selected reaction monitoring (SRM) mass spectrometry 10.1167/iovs.13-12777
Symptom assessment in patients with functional and primary acquired nasolacrimal duct obstruction before and after successful dacryocystorhinostomy surgery: A prospective study 10.1136/bjo.2007.119834
Session I: Discussion and summary 10.1097/ICL.0b013e318157aa18
Local synthesis of sex hormones: Are there consequences for the ocular surface and dry eye? 10.1136/bjophthalmol-2017-310610
Review of contact lens–related complications 10.1097/ICL.0000000000000481
Validating a new device for measuring tear evaporation rates 10.1111/opo.12096
The epidemiology of contact lens related infiltrates 10.1097/OPX.0b013e3180485d5f
Risk Factors for Nonulcerative Contact Lens Complications in an Ophthalmic Accident and Emergency Department. A Case-Control Study 10.1016/j.ophtha.2008.09.053
An early assessment of silicone hydrogel safety: Pearls and pitfalls, and current status 10.1097/ICL.0b013e318157c77f
Do swimming goggles limit microbial contamination of contact lenses? 10.1097/OPX.0b013e31820f15a6
Contact lens case contamination during daily wear of silicone hydrogels 10.1097/OPX.0b013e3181e19eda
Focused tortuosity definitions based on expert clinical assessment of corneal subbasal nerves 10.1167/iovs.15-17284
Contact lens-induced discomfort and inflammatory mediator changes in tears 10.1097/ICL.0000000000000237
The Asia Cornea Society Infectious Keratitis Study: A Prospective Multicenter Study of Infectious Keratitis in Asia 10.1016/j.ajo.2018.07.040
Association of single nucleotide polymorphisms of interleukins-1β, -6, and -12B with contact lens keratitis susceptibility and severity 10.1016/j.ophtha.2012.01.031
Topical Review: Effects of Contact Lens Wear on Corneal, Conjunctival, and Lid Margin Sensitivity 10.1097/OPX.0000000000001429
Effects of Refraction and Axial Length on Childhood Optic Disk Parameters Measured by Optical Coherence Tomography 10.1016/j.ajo.2007.05.010
The development and validation of the health proneness questionnaire 10.1007/s10880-006-9040-9
Pediatric Microbial Keratitis in Queensland, Australia (2005 to 2015) 10.1097/ICO.0000000000002053
Impact of cleaning regimens in silver-impregnated and hydrogen peroxide lens cases 10.1097/ICL.0b013e318233c901
The TFOS International Workshop on Contact Lens Discomfort: Report of the contact lens interactions with the tear film subcommittee 10.1167/iovs.13-13235
The myopia movement 10.1111/cxo.13040
Therapeutic treatment of keratoconus: A survey of local optometric practice criteria 10.1111/cxo.12233
Contact lens storage case hygiene practice and storage case contamination 10.1097/ICL.0000000000000070
The penetrance and characteristics of contact lens wear in Australia 10.1111/cxo.12078
Work-related musculoskeletal discomfort and injuries in Australian optometrists 10.3233/WOR-2012-0399-1864
Higher risk taking propensity of contact lens wearers is associated with less compliance 10.1016/j.clae.2010.10.004
Grading contact lens-related microbial keratitis: Relevance to disease burden 10.1097/OPX.0b013e31817dba2e
The effects of a hydrating mask compared to traditional warm compresses on tear film properties in meibomian gland dysfunction 10.1016/j.clae.2017.09.006
Development and evaluation of evidence-based guidelines on contact lens-related microbial keratitis 10.1016/j.clae.2007.10.003
Quality of 2019 American optometric association clinical practice guideline for diabetic eye care 10.1111/opo.12763
Broad spectrum of antibacterial activity of a new multipurpose disinfecting solution 10.1097/ICL.0b013e318030c983
Can the appropriateness of eye care be measured through cross-sectional retrospective patient record review in eye care practices in Australia? the icaretrack feasibility study 10.1136/bmjopen-2018-024298
TFOS DEWS II Report Executive Summary 10.1016/j.jtos.2017.08.003
Retinal and optic disc findings in adolescence: A population-based OCT study 10.1167/iovs.07-0699
Factors affecting corneal and conjunctival sensitivity measurement 10.1097/OPX.0b013e3181694f96
A longitudinal study of trends in keratitis in Australia 10.1097/ICO.0b013e318156cb1f
A critical role for CCL2 and CCL3 chemokines in the regulation of polymorphonuclear neutrophils recruitment during corneal infection in mice 10.1038/sj.icb.7100082
Clinical outcomes of keratitis 10.1111/j.1442-9071.2007.01511.x
Understanding clinical and immunological features associated with Pseudomonas and Staphylococcus keratitis 10.1016/j.clae.2020.11.014
Pilot Study of Corneal Sensitivity and Its Association in Keratoconus 10.1097/ICO.0000000000001077
The TFOS International Workshop on Contact Lens Discomfort: Introduction 10.1167/iovs.13-13195
Visual and non-visual factors associated with patient satisfaction and quality of life in LASIK 10.1038/eye.2011.151
Referral pathways and management of contact lens-related microbial keratitis in Australia and New Zealand 10.1111/j.1442-9071.2008.01722.x
Assessing the sensory function of the ocular surface: Implications of use of a non-contact air jet aesthesiometer versus the Cochet-Bonnet aesthesiometer 10.1016/j.exer.2011.02.016
In vivo efficacy of silver-impregnated barrel contact lens storage cases 10.1016/j.clae.2020.08.001
Corneal epithelial dendritic cell density in the healthy human cornea: A meta-analysis of in-vivo confocal microscopy data 10.1016/j.jtos.2019.07.001
How do Australian optometrists manage work-related physical discomfort? 10.1111/j.1444-0938.2012.00711.x
Sex hormones and the dry eye 10.1111/cxo.12147
A pilot study on corneal Langerhans cells in keratoconus 10.1016/j.clae.2017.10.005
Therapeutic endorsement enhances compliance with national glaucoma guidelines in Australian and New Zealand optometrists 10.1111/opo.12197
Signs, symptoms, and comorbidities in contact lens-related microbial keratitis 10.1097/OPX.0b013e3181ae1b69
Developing an instrument to assess vision-related and subjective quality of life in children with intellectual disability: Data collection and preliminary analysis in a Chinese population 10.1111/j.1475-1313.2008.00564.x
Risk factors for moderate and severe microbial keratitis in daily wear contact lens users 10.1016/j.ophtha.2012.01.052
What do clinical optometrists like about their job? 10.1111/cxo.12017
Role of percent peripheral tissue ablated on refractive outcomes following hyperopic LASIK 10.1371/journal.pone.0170559
Vision and driving status of older Australians with cataract: an investigation of public hospital waiting lists 10.1111/cxo.12414
Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis 10.1099/jmm.0.2008/003723-0
Preinflammatory Signs in Established Reusable and Disposable Contact Lens Wearers 10.1097/OPX.0000000000001129
Risk factors and causative organisms in microbial keratitis in daily disposable contact lens wear 10.1371/journal.pone.0181343
Comparative limitations and benefits of liquid chromatography – mass spectrometry techniques for analysis of sex steroids in tears 10.1016/j.exer.2018.11.015
Bacterial biofilm in silver-impregnated contact lens cases 10.1016/j.clae.2019.11.004
Quantum Dots in Ophthalmology: A Literature Review 10.1080/02713683.2019.1660793
In vivo assessment of antimicrobial efficacy of silver-impregnated contact lens storage cases 10.1167/iovs.11-8197
Immune defense single nucleotide polymorphisms and recruitment strategies associated with contact lens keratitis 10.1016/j.ophtha.2012.05.020
Thirty years of “quiet eye” with etafilcon A contact lenses: Additional considerations 10.1016/j.clae.2020.06.004
Structural and functional changes in corneal innervation after laser in situ keratomileusis and their relationship with dry eye 10.1007/s00417-015-3120-1
Attitudes and barriers to evidence-based practice in optometry educators 10.1097/OPX.0000000000000550
The TFOS International Workshop on Contact Lens Discomfort: Executive summary 10.1167/iovs.13-13212
Pre-operative quality of life and psychological factors that influence patient decision making in LASIK 10.1038/eye.2009.115
Effect of age and contact lens wear on corneal epithelial dendritic cell distribution, density, and morphology 10.1016/j.clae.2019.05.002
The effects of transdermal testosterone and oestrogen therapy on dry eye in postmenopausal women: A randomised, placebo-controlled, pilot study 10.1136/bjophthalmol-2016-309498
Role of hypo-osmotic saline drops in ocular comfort during contact lens wear 10.1016/j.clae.2010.01.001
Risk Factors for Microbial Keratitis with Contemporary Contact Lenses. A Case-Control Study 10.1016/j.ophtha.2008.05.003
Reasons for refusing cataract surgery in illiterate individuals in a tribal area of Andhra Pradesh, India 10.3109/09286586.2014.903980
Investigation of attributes which guide choice in cataract surgery services in urban Sydney, Australia 10.1111/cxo.12653
Corneal Indentation in the Early Management of Acute Angle Closure 10.1016/j.ophtha.2008.08.032
Osmolality and tear film dynamics 10.1111/j.1444-0938.2011.00634.x
Trends in contact lens microbial keratitis 1999 to 2015: a retrospective clinical review 10.1111/ceo.13484
Studies of contact lens-related microbial keratitis in Australia and New Zealand: New learnings 10.1097/ICL.0b013e318157c57e
Measurements of solutions and contact lenses with a vapor pressure osmometer 10.1097/OPX.0b013e318046552f
Effects of lipid supplements on tear biochemistry in contact lens wearers 10.1097/OPX.0000000000000947
Standardising the cataract referral process for public hospitals: perspectives of optometrists in New South Wales, Australia 10.1111/cxo.12928
A population survey of the penetrance of contact lens wear in Australia: Rationale, methodology and results 10.3109/09286580903144753
Swapna Shanbhag
Shanbhag Swapna / Swapna S Shanbhag
ORCID: 0000-0003-2455-0536
Descemet Membrane Endothelial Keratoplasty 10.1001/jamaophthalmol.2015.0475
The Boston keratoprosthesis 10.1097/icu.0000000000000373
Simple Limbal Epithelial Transplantation 10.1016/j.ophtha.2015.12.042
Keratolimbal allograft for limbal stem cell deficiency after severe corneal chemical injury: a systematic review 10.1136/bjophthalmol-2017-311249
Orbital Chondroma: A rare mesenchymal tumor of orbit 10.4103/0301-4738.162638
The grave necessity to make eye bank specular microscopy mandatory in all eye banks in the subcontinent to improve utilization of scarce donor corneas 10.4103/0301-4738.124754
Limbal Stem Cell Deficiency—Demography and Underlying Causes 10.1016/j.ajo.2018.01.020
Chronic Ocular Sequelae of Stevens-Johnson Syndrome in Children: Long-term Impact of Appropriate Therapy on Natural History of Disease 10.1016/j.ajo.2018.01.028
Boston keratoprosthesis type 1 for limbal stem cell deficiency after severe chemical corneal injury: A systematic review 10.1016/j.jtos.2018.03.007
Comparative Outcomes of Boston Keratoprosthesis Type 1 Implantation Based on Vision in the Contralateral Eye 10.1097/ico.0000000000001721
Surgical management of acquired implantation iris cysts: indications, surgical challenges and outcomes 10.1136/bjophthalmol-2018-312738
The Persistent Dilemma of Microbial Keratitis: Global Burden, Diagnosis, and Antimicrobial Resistance 10.1016/j.survophthal.2018.12.003
Sutureless amniotic membrane transplantation with cyanoacrylate glue for acute Stevens-Johnson syndrome/toxic epidermal necrolysis 10.1016/j.jtos.2019.03.001
Incidence, demographics, types and risk factors of dry eye disease in India: Electronic medical records driven big data analytics report I 10.1016/j.jtos.2019.02.007
Commentary: The human amniotic membrane: Fortifying nature's gift to ophthalmology. 10.4103/ijo.IJO_2062_18
Controversial role of retinoids in ocular surface disease 10.1136/bjophthalmol-2019-314241
Autologous limbal stem cell transplantation: a systematic review of clinical outcomes with different surgical techniques 10.1136/bjophthalmol-2019-314081
Glaucoma Management in Patients with Aniridia and Boston Type 1 Keratoprosthesis 10.1016/j.ajo.2019.06.018
Limbal Epithelial and Mesenchymal Stem Cell Therapy for Corneal Regeneration 10.1080/02713683.2019.1639765
Authors' Response: Povidone-Iodine for the Treatment of Microbial Keratitisthis 10.1016/j.survophthal.2019.06.005
Long-term impact of a treatment protocol for acute ocular involvement in Stevens-Johnson syndrome/toxic epidermal necrolysis 10.1016/j.ajo.2019.07.006
Simple limbal epithelial transplantation (SLET): Review of indications, surgical technique, mechanism, outcomes, limitations, and impact 10.4103/ijo.ijo_117_19
Clinical clues predictive of Stevens-Johnson syndrome as the cause of chronic cicatrising conjunctivitis 10.1136/bjophthalmol-2019-314928
Authors’ response to: The Perils and Pitfalls of Big Data analysis in medicine 10.1016/j.jtos.2019.08.009
Multidisciplinary Treatment to Restore Vision in Ocular Burns. 10.1093/jbcr/irz201
Society of Dermatology Hospitalists supportive care guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults. 10.1016/j.jaad.2020.02.066
Infectious corneal ulceration: a proposal for neglected tropical disease status. 10.2471/BLT.19.232660
Long-term outcomes of amniotic membrane treatment in acute Stevens-Johnson syndrome/toxic epidermal necrolysis 10.1016/j.jtos.2020.03.004
Multidisciplinary care in Stevens-Johnson syndrome 10.1177/2040622319894469
The effects of systemic cyclosporine in acute Stevens-Johnson syndrome/toxic epidermal necrolysis on ocular disease 10.1016/j.jtos.2020.05.003
Outcomes of the Boston type 1 and the Aurolab keratoprosthesis in eyes with limbal stem cell deficiency 10.1136/bjophthalmol-2020-316369
Lid-Related Keratopathy in Stevens-Johnson Syndrome: Natural Course and Impact of Therapeutic Interventions in Children and Adults 10.1016/j.ajo.2020.07.006
Lacrimal Gland Involvement in Severe Dry Eyes after Stevens-Johnson Syndrome 10.1016/j.ophtha.2020.08.016
Palpebral lobe of the human lacrimal gland: morphometric analysis in normal versus dry eyes 10.1136/bjophthalmol-2020-316929
Cataract Surgery in Dry Eye Disease: Visual Outcomes and Complications 10.3389/fmed.2020.575834
Chronic cicatrizing conjunctivitis: A review of the differential diagnosis and an algorithmic approach to management 10.4103/ijo.ijo_604_20
Oral mucous membrane grafts for total symblepharon and lid margin keratinisation post Stevens-Johnson syndrome 10.1136/bcr-2020-239383
Simultaneous surgical management of unilateral limbal stem cell deficiency and symblepharon post chemical burn 10.1136/bcr-2020-237234
Serial anterior segment optical coherence tomography post autologous simple limbal epithelial transplantation 10.1136/bcr-2020-236692
Commentary: The role of amniotic membrane transplantation in the management of acute ocular chemical burns 10.4103/ijo.ijo_2040_20
Genetic Markers for Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis in the Asian Indian Population: Implications on Prevention 10.3389/fgene.2020.607532
An Evidence-Based Strategic Approach to Prevention and Treatment of Dry Eye Disease, a Modern Global Epidemic 10.3390/healthcare9010089
A beginner's guide to mucous membrane grafting for lid margin keratinization: Review of indications, surgical technique and clinical outcomes 10.4103/ijo.IJO_1273_20
Tear secretion from the lacrimal gland: variations in normal versus dry eyes. 10.1136/bjophthalmol-2020-318159
Lid margin keratinization in Stevens-Johnson syndrome: Review of pathophysiology and histopathology 10.1016/j.jtos.2021.03.011
Chronic ocular complications in lamotrigine vs. trimethoprim-sulfamethoxazole induced Stevens-Johnson syndrome/toxic epidermal necrolysis 10.1016/j.jtos.2021.04.009
Diphtheroids as Corneal Pathogens in Chronic Ocular Surface Disease in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. 10.1097/ico.0000000000002696
Commentary: Ocular graft versus host disease: Need for multidisciplinary care. 10.4103/ijo.ijo_772_21
Histopathological Characteristics of Limbal Stem Cell Deficiency Secondary to Chronic Vernal Keratoconjunctivitis 10.1097/ico.0000000000002775
Chronic Ocular Sequelae and Subsequent Surgical Interventions in Stevens–Johnson Syndrome After Amniotic Membrane Transplantation 10.1097/ico.0000000000002816
High-Resolution Optical Coherence Tomography Angiography Characteristics of Limbal Stem Cell Deficiency 10.3390/diagnostics11061130
Clinical Aspects of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications in India 10.3389/fmed.2021.643955
Stephanie Watson
Watson Stephanie / Stephanie L Watson
ORCID: 0000-0001-6699-1765
Clinical outcomes of xeno-free expansion and transplantation of autologous ocular surface epithelial stem cells via contact lens delivery: A prospective case series 10.1186/s13287-015-0009-1
Seeing red: Over-the-counter chloramphenicol 10.1111/ceo.12497
Retinoic acid and the ocular surface 10.1016/j.survophthal.2014.10.001
Efficacy and Safety of Topical Atorvastatin for the Treatment of Dry Eye Associated with Blepharitis: A Pilot Study 10.1159/000367851
Inappropriate use of topical chloramphenicol results in vision loss 10.1111/ceo.12465
Unusual limbal lesion in neurofibromatosis type 1 10.1097/ICO.0000000000000353
Severe alkali burns from beer line cleaners warrant mandatory safety guidelines 10.5694/mja13.00064
Long-term adhesion of cyanoacrylate on human cornea 10.1111/ceo.12300
Recent cluster of childhood microbial keratitis due to orthokeratology 10.1111/ceo.12302
Bilateral corneal infections associated with topical steroid therapy prophylaxis for cytarabine arabinoside-induced keratoconjunctivitis 10.1038/leu.2013.237
Corneal blindness: A global problem 10.1111/ceo.12330
Clinical study of therapeutic ocular surface medium for persistent epithelial defect 10.1159/000355065
Interventions for recurrent corneal erosion: A Cochrane Systematic review 10.1038/eye.2013.191
Limbal dermoid epithelium shares phenotypic characteristics common to both hair epidermal and limbal epithelial stem cells 10.3109/02713683.2013.780625
Treatment of traumatic corneal abrasions: A three-arm, prospective, randomized study 10.1159/000347125
Current status and future prospects for cultured limbal tissue transplants in Australia and New Zealand 10.1111/j.1442-9071.2012.02877.x
Diversity of microbial species implicated in keratitis: A review 10.2174/1874364101206010110
Interventions for recurrent corneal erosions 10.1002/14651858.CD001861.pub3
SurgiLux: A novel thin film, laser-activated bioadhesive for corneal repair 10.4028/www.scientific.net/AMR.506.7
Corneal melting two weeks after pterygium excision with topical mitomycin C: Successfully treated with lamellar keratoplasty and amnion membrane transplantation 10.1159/000336452
Vitronectin: A matrix support factor for human limbal epithelial progenitor cells 10.1167/iovs.11-8140
Tunnel vision and night blindness in a 52-year-old man 10.5694/mja11.10292
Sutureless sealing of penetrating corneal wounds using a laser-activated thin film adhesive 10.1002/lsm.21076
Chitosan-vancomysin composite biomaterial as a laser activated surgical adhesive with regional antimicrobial activity 10.1021/bm101028g
Clinical trials of therapeutic ocular surface medium for moderate to severe dry eye 10.1097/ICO.0b013e3181d82f5e
Use of intraoperative fourier-domain anterior segment optical coherence tomography during descemet stripping endothelial keratoplasty 10.1016/j.ajo.2010.04.017
The effect of mesenchymal stem cell conditioned media on corneal stromal fibroblast wound healing activities 10.1136/bjo.2009.165837
Reply to aniridia-to be or not to be? 10.1097/TP.0b013e3181c832a8
Reply to contact lens-based expansion and transplantation of autologous epithelial progenitors for ocular surface reconstruction: Crossover control 10.1097/01.TP.0000368789.42492.f2
Nourish and nurture: Development of a nutrient ocular lubricant 10.1167/iovs.08-1991
A contact lens-based technique for expansion and transplantation of autologous epithelial progenitors for ocular surface reconstruction 10.1097/TP.0b013e3181a4bbf2
The effect of therapeutic human serum drops on corneal stromal wound-healing activity 10.1080/02713680802254790
Interventions for recurrent corneal erosions 10.1002/14651858.CD001861.pub2
Spontaneous resolution of corneal oedema following Descemet's detachment 10.1111/j.1442-9071.2006.01319.x
Legeais bioKpro III keratoprosthesis implantation: Long term results in seven patients 10.1136/bjo.2006.092510
Patterns of Rejection after Deep Lamellar Keratoplasty 10.1016/j.ophtha.2006.01.006
Spectrum of clear corneal incision cataract wound infection 10.1016/j.jcrs.2005.02.033
Improved safety in contemporary LASIK 10.1016/j.ophtha.2005.02.012
Cornea-sparing laser in situ keratomileusis: Ablation on the flap 10.1016/j.jcrs.2004.10.040
Comparison of deep lamellar keratoplasty and penetrating keratoplasty in patients with keratoconus 10.1016/j.ophtha.2004.02.010
A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis 10.1097/00132578-200407000-00005
A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis 10.1016/j.ophtha.2003.05.035
Corneal valance: A useful sign in epithelial basement membrane dystrophy [8] 10.1038/sj.eye.6700412
Confocal microscopy of Thygeson's superficial punctate keratopathy 10.1097/00003226-200305000-00003
Pituitary apoplexy presenting with an orbital bruit 10.1046/j.1442-9071.2002.00541.x
Treatment of superior limbic keratoconjunctivitis with a unilateral bandage contact lens [18] 10.1136/bjo.86.4.485
Multifocal chorioretinal atrophy associated with Herpes zoster ophthalmicus 10.1046/j.1442-9071.2001.d01-30.x
Xerophthalmia and Vitamin A deficiency in an autistic child with a restricted diet 10.1136/bcr-2015-209413
Use of topical retinoic acid for limbal stem cell failure: A retrospective clinical case series 10.1111/ceo.12663
Dry eyes and AIs: If you don't ask you won't find out 10.1016/j.breast.2015.08.008
Possible role of aqueous humour dynamics in Descemet's membrane detachment resolution 10.1111/ceo.12957
The epidemiology of Open Globe Injuries presenting to a tertiary referral eye hospital in Australia 10.1016/j.injury.2017.04.035
Meibomian gland disease and the microbiotome: is it time for ocular probiotics? 10.1111/ceo.12901
Light-based epilation device-related injury to the cornea. 10.5694/mja16.00478
Persistent Epithelial Defects and Corneal Opacity After Collagen Cross-Linking With Substitution of Dextran (T-500) With Dextran Sulfate in Compounded Topical Riboflavin. 10.1097/ico.0000000000001134
Vitamin A deficiency and xerophthalmia in children of a developed country 10.1111/jpc.13243
The Impact of Topical Corticosteroids Used in Conjunction with Antiamoebic Therapy on the Outcome of Acanthamoeba Keratitis 10.1016/j.ophtha.2016.01.020
Established and emerging ancillary techniques in management of microbial keratitis: A review 10.1136/bjophthalmol-2015-307371
Hemorrhagic descemet membrane detachment following syphilitic interstitial keratitis 10.1097/ICO.0000000000000889
Ocular problems in extreme sports: High-altitude trekking and surfing 10.1007/978-3-319-28265-7_5
Defining Ocular Surface Disease Activity and Damage Indices by an International Delphi Consultation 10.1016/j.jtos.2016.08.005
Nature and incidence of severe limbal stem cell deficiency in Australia and New Zealand 10.1111/ceo.12813
Contact lens delivery of stem cells for restoring the ocular surface 10.1016/B978-0-08-100147-9.00009-2
Eye Injuries across history and the evolution of eye protection 10.1111/aos.14086
Are current ophthalmology clinical practices relating to blue light‐filtering intraocular lenses evidence‐based? 10.1111/ceo.13653
The clinical and microbiological features and outcomes of fungal keratitis over 9 years in Sydney, Australia 10.1111/myc.13009
Antimicrobial resistance trends in bacterial keratitis over 5 years in Sydney, Australia 10.1111/ceo.13672
Statins in Neuro-ophthalmology 10.1080/01658107.2020.1755872
A qualitative exploration of the experience and quality of life of patients, and their family carers, admitted to a specialist eye hospital with microbial keratitis 10.21203/rs.2.9130/v2
Diagnosis using polymerase chain reaction and outcomes in herpes simplex keratitis 10.1111/aos.14601
A qualitative exploration of the experience and quality of life of patients, and their family carers, admitted to a specialist eye hospital with microbial keratitis 10.21203/rs.2.9130/v3
Travel associated microbial keratitis: is resistance a risk? 10.1016/j.tmaid.2020.101903
Pediatric Microbial Keratitis: Experience From Tertiary Referral Centers in New South Wales, Australia. 10.1097/inf.0000000000002723
Ocular trauma and prevention measures 10.1111/ceo.13850
Topical Steroids as Adjunctive Therapy for Bacterial Keratitis: Evidence From a Retrospective Case Series of 313 Cases. 10.1097/apo.0000000000000320
Corneal Sealants in Clinical Use: A Systematic Review 10.1080/02713683.2020.1764052
Microbial keratitis in Sydney, Australia: risk factors, patient outcomes, and seasonal variation 10.1007/s00417-020-04681-0
The Impact on Work Patterns of Implementing the Save Sight Keratoconus Registry in the Hospital Setting. 10.1097/ico.0000000000002159
Visualizing the Contribution of Keratin-14+ Limbal Epithelial Precursors in Corneal Wound Healing 10.1016/j.stemcr.2018.11.014
An electrophysiological and histological study of trypsin induced demyelination 10.1016/0022-510x(94)90260-7
The current state of stem cell therapy for ocular disease 10.1016/j.exer.2018.07.019
Statins in ophthalmology 10.1016/j.survophthal.2019.01.013
Common eye infections 10.18773/austprescr.2018.016
Infectious corneal ulceration: a proposal for neglected tropical disease status 10.2471/blt.19.232660
Gender differences in Australasian ophthalmologists' experiences of the workplace 10.1111/ceo.13487
Keratoconus Natural Progression 10.1016/j.ophtha.2019.02.029
Clinical translation of recommendations from randomized trials for management of herpes simplex virus keratitis 10.1111/ceo.13319
Acanthamoeba keratitis in Australia: demographics, associated factors, presentation and outcomes: a 15-year case review 10.1038/s41433-019-0589-6
The Spectrum of Microbial Keratitis: An Updated Review 10.2174/1874364101913010100
Improving the Efficiency and the Technique of the Corneal Scrape Procedure via an Evidence Based Instructional Video at a Quaternary Referral Eye Hospital 10.1080/02713683.2019.1676910
Microbial Keratitis and Ocular Surface Disease: A 5-Year Study of the Microbiology, Risk Factors and Clinical Outcomes in Sydney, Australia 10.1080/02713683.2019.1631852
Hospital admission for blood collection for the preparation of autologous serum eye drops 10.1016/j.transci.2019.08.028
Development, Implementation, and Evaluation of Treatment Guidelines for Herpes Simplex Keratitis in Sydney, Australia 10.1097/ico.0000000000002273
Dose-dependent benzalkonium chloride toxicity imparts ocular surface epithelial changes with features of dry eye disease 10.1016/j.jtos.2019.11.006
Measurement of Quality of Life in Keratoconus 10.1097/ico.0000000000002170
Vision-Related Quality of Life in Keratoconus 10.1097/ico.0000000000001899
Psychometric Properties of the Keratoconus Outcomes Research Questionnaire 10.1097/ico.0000000000002169
The impact of Fred Hollows on Australian ophthalmic research 10.1111/ceo.13617
Viral conjunctivitis: a retrospective study in an Australian hospital 10.1016/j.clae.2019.07.001
Eye injury registries – A systematic review 10.1016/j.injury.2019.07.019
The myopic shift associated with hyperbaric oxygen administration is reduced when using a mask delivery system compared to a hood – a randomised controlled trial 10.28920/dhm49.4.245-252
HMG-CoA reductase expression in human eyelid tissue and in a human meibomian gland epithelial cell line 10.1007/s00417-019-04247-9
Effectiveness of pharmaceutical interventions for meibomian gland dysfunction: An evidence-based review of clinical trials 10.1111/ceo.13460
Clinical use of topical hypertonic saline eye drops in a quaternary referral eye care centre over 5 years in Sydney, Australia 10.1111/ceo.13449
Association of dyslipidaemia and oral statin use, and dry eye disease symptoms in the Blue Mountains Eye Study 10.1111/ceo.13388
Microbial keratitis associated with long‐term orthokeratology 10.1111/ceo.13386
Keratitis antimicrobial resistance surveillance program, Sydney, Australia: 2016 Annual Report 10.1111/ceo.13364
Central corneal thickness changes and horizontal corneal diameter in premature infants: A prospective analysis. 10.1097/md.0000000000013357
Clinical Registries in Ophthalmology 10.1016/j.ophtha.2018.12.030
Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand 10.1038/s41433-018-0155-7
Corneal biopsy for diagnosis of recalcitrant microbial keratitis 10.1007/s00417-018-3981-1
Visualizing the Fate of Transplanted K14-Confetti Corneal Epithelia in a Mouse Model of Limbal Stem Cell Deficiency 10.1167/iovs.17-23557
Investigation of corneal endothelial changes post selective laser trabeculoplasty 10.1111/ceo.13172
Native and synthetic scaffolds for limbal epithelial stem cell transplantation 10.1016/j.actbio.2017.10.037
Reducing oral contamination during corneal scrapes 10.1136/bmjophth-2016-000044
The Efficacy of N-Butyl-2 Cyanoacrylate (Histoacryl) for Sealing Corneal Perforation 10.4172/2155-9570.1000420
A Comparison of Lamellar and Penetrating Keratoplasty Outcomes 10.1016/j.ophtha.2013.12.017
Predisposing factors, microbiological features and outcomes of patients with clinical presumed concomitant microbial and herpes simplex keratitis 10.1038/s41433-021-01440-1
Item banks for measurement of refractive error‐specific quality of life 10.1111/opo.12792
Interventions for recurrent corneal erosions 10.1002/14651858.CD001861.pub4
Application of a novel film sealant technology for penetrating corneal wounds: An ex-vivo study 10.3390/app10093193
Bacterial Ocular Surveillance System (BOSS) Sydney, Australia 2017-2018 10.33321/cdi.2020.44.86
Quality-of-life researchers in ocular allergy may benefit from the newer methods 10.1016/j.jaip.2020.09.067
The risk of complications of uveitis in a district hospital cohort 10.1136/bjo.2002.013334
Epidemiology, aetiology and outcome of paediatric ocular trauma in Sydney 10.1111/jpc.15531
Dry eye signs and symptoms in patients on aromatase inhibitor therapy 10.1038/s41433-021-01538-6
Outcomes of Patients with Herpes Simplex Keratitis Before and After the Implementation of a New Treatment Guideline in Sydney, Australia 10.1097/APO.0000000000000368
Predictors of progression in untreated keratoconus: A Save Sight Keratoconus Registry study 10.1136/bjophthalmol-2020-317547
The Save Sight Keratoconus Registry – Optometry Module: an opportunity to use real-world data to advance eye care 10.1080/08164622.2021.1924626
Clinical outcomes of herpes simplex keratitis: Two‐year experience from a quaternary eye care centre in Sydney, Australia 10.1111/opo.12859
John Kempen
Kempen John
ORCID: 0000-0002-2967-4792
Periocular Triamcinolone vs. Intravitreal Triamcinolone vs. Intravitreal Dexamethasone Implant for the Treatment of Uveitic Macular Edema 10.1016/j.ophtha.2018.08.021
Prevalence and causes of blindness and vision impairment: magnitude, temporal trends and projections in South and Central Asia 10.1136/bjophthalmol-2018-312292
Prevalence and causes of vision loss in sub-Saharan Africa in 2015: magnitude, temporal trends and projections 10.1136/bjophthalmol-2019-315217
SARS CoV-2 Serosurvey in Addis Ababa, Ethiopia 10.1101/2020.06.23.20137521
Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic 10.1136/bjophthalmol-2020-316776
Incidence and Outcome of Uveitic Glaucoma in Eyes With Intermediate, Posterior, or Panuveitis Followed up to 10 Years After Randomization to Fluocinolone Acetonide Implant or Systemic Therapy 10.1016/j.ajo.2020.06.038
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Descriptive Review of Tubercular Uveitis in Paediatric Population 10.1080/09273948.2020.1781197
Twenty-four Month Outcomes in the Collaborative Ocular Tuberculosis Study (COTS)-1: Defining the "Cure" in Ocular Tuberculosis. 10.1080/09273948.2020.1761401
Prevalence and causes of vision loss in East Asia in 2015: magnitude, temporal trends and projections 10.1136/bjophthalmol-2018-313308
Factors Predictive of Remission of Chronic Anterior Uveitis 10.1016/j.ophtha.2019.11.020
Infectious corneal ulceration: a proposal for neglected tropical disease status 10.2471/BLT.19.232660
Patterns of Uveitis among Patients Attending Jimma University Department of Ophthalmology, Jimma, Ethiopia. 10.1080/09273948.2019.1644348
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 165 Patients with Tubercular Anterior Uveitis 10.1080/09273948.2020.1761400
Visual Morbidity in Ocular Tuberculosis - Collaborative Ocular Tuberculosis Study (COTS)-1: Report #6 10.1080/09273948.2020.1774905
The Collaborative Ocular Tuberculosis Study (COTS) Consensus (CON) Group Meeting Proceedings 10.1080/09273948.2020.1716025
Standardization of Nomenclature for Ocular Tuberculosis - Results of Collaborative Ocular Tuberculosis Study (COTS) Workshop 10.1080/09273948.2019.1653933
The Changing Global Epidemic of HIV and Ocular Disease 10.1080/09273948.2020.1751214
Comparison Between Methotrexate and Mycophenolate Mofetil Monotherapy for the Control of Noninfectious Ocular Inflammatory Diseases 10.1016/j.ajo.2019.07.008
Visual Acuity Outcome over Time in Non-Infectious Uveitis 10.1080/09273948.2019.1687733
Current ophthalmology practice patterns for syphilitic uveitis 10.1136/bjophthalmol-2018-313207
Tubercular Uveitis: Nuggets from Collaborative Ocular Tuberculosis Study (COTS)-1 10.1080/09273948.2019.1646774
ISOPT Clinical Hot Topic Panel Discussion on Uveitis and Inflammation 10.1089/jop.2019.0035
THE COLLABORATIVE OCULAR TUBERCULOSIS STUDY (COTS)-1 A Multinational Review of 251 Patients With Tubercular Retinal Vasculitis 10.1097/IAE.0000000000002194
Prevalence and causes of vision loss in North Africa and Middle East in 2015: magnitude, temporal trends and projections 10.1136/bjophthalmol-2018-312068
Prevalence and causes of vision loss in Latin America and the Caribbean in 2015: magnitude, temporal trends and projections 10.1136/bjophthalmol-2017-311746
Techniques for improving ophthalmic studies performed on administrative databases 10.1080/09286586.2018.1554160
Fluorometholone 0.1% as Ancillary Therapy for A Trachomatous Trichiasis Surgery: Randomized Clinical Trial 10.1016/j.ajo.2018.09.017
Authors Reply to Letter to the Editor- In Response to: Comment on Durrani et al.'s ``Adalimumab for Ocular Inflammation'' 10.1080/09273948.2017.1379545
Diabetic Retinopathy in Hispanics: A Perspective on Disease Burden 10.1016/j.ajo.2018.08.021
Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections 10.1136/bjophthalmol-2017-311258
Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial 10.1136/bjophthalmol-2017-311610
Association of Hypovitaminosis D With Increased Risk of Uveitis in a Large Health Care Claims Database 10.1001/jamaophthalmo1.2018.0642
Prevalence and causes of vision loss in South-east Asia and Oceania in 2015: magnitude, temporal trends and projections 10.1136/bjophthalmol-2018-311946
Difluprednate 0.05% versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: Pooled Efficacy Analysis of Two Phase 3 Studies 10.1080/09273948.2017.1407433
Global causes of blindness and distance vision impairment 1990-2020: a systematic review and meta-analysis 10.1016/S2214-109X(17)30393-5
Risk of Ocular Hypertension in Adults with Noninfectious Uveitis 10.1016/j.ophtha.2017.03.041
Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis 10.1016/S2214-109X(17)30293-0
Sensitivity and Specificity of Laser-Scanning In Vivo Confocal Microscopy for Filamentous Fungal Keratitis: Role of Observer Experience REPLY 10.1016/j.ajo.2017.07.001
Adalimumab for Ocular Inflammation 10.3109/09273948.2015.1134581
Morphological assessment of the retina in uveitis 10.1186/s12348-016-0103-2
Remission of Intermediate Uveitis: Incidence and Predictive Factors 10.1016/j.ajo.2015.12.034
Pattern of Pediatric Uveitis Seen at a Tertiary Referral Center from India 10.3109/09273948.2015.1012298
Risk of Retinal Neovascularization in Cases of Uveitis 10.1016/j.ophtha.2015.10.056
Acute onset anterior uveitis after darbepoetin alfa infusion 10.1186/s12348-015-0061-0
Demand for Tertiary Eye Care Services in Developing Countries 10.1016/j.ajo.2015.06.005
The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis 10.1016/j.ophtha.2015.06.041
Association Between Long-Lasting Intravitreous Fluocinolone Acetonide Implant vs Systemic Anti-inflammatory Therapy and Visual Acuity at 7 Years Among Patients With Intermediate, Posterior, or Panuveitis 10.1001/jama.2017.5103
Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) 10.1016/j.ajo.2015.09.017
Cataract Surgery Outcomes in Uveitis The Multicenter Uveitis Steroid Treatment Trial 10.1016/j.ophtha.2015.09.022
Outcome of Treatment of Uveitic Macular Edema The Multicenter Uveitis Steroid Treatment Trial 2-Year Results 10.1016/j.ophtha.2015.07.036
Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis Fifty-foureMonth Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study 10.1016/j.ophtha.2015.06.042
Quality of Life and Risks Associated with Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, or Panuveitis Fifty-foure-Month Results of the Multicenter Uveitis Steroid Treatment Trial and Follow-up Study 10.1016/j.ophtha.2015.06.043
Uveitis Reactivation in Children Treated With Tumor Necrosis Factor Alpha Inhibitors 10.1016/j.ajo.2015.04.016
Immunosuppressive Therapy and Cancer Risk in Ocular Inflammation Patients: Fresh Evidence and More Questions 10.1016/j.ophtha.2014.11.023
Design and Interpretation of Clinic-Based Studies in Uveitis 10.3109/09273948.2015.1074028
Outcomes of Cataract Surgery in Patients With Uveitis: A Systematic Review and Meta-analysis 10.1016/j.ajo.2014.06.018
Risk of Cataract among Subjects with Acquired Immune Deficiency Syndrome Free of Ocular Opportunistic Infections 10.1016/j.ophtha.2014.06.014
Immune Markers Predictive of Neuropsychiatric Symptoms in HIV-Infected Youth 10.1128/CVI.00463-14
Ocular Toxicity in BRAF Mutant Cutaneous Melanoma Patients Treated With Vemurafenib 10.1016/j.ajo.2014.07.003
Periocular Corticosteroid Injections in Uveitis Effects and Complications 10.1016/j.ophtha.2014.05.021
Cost-Effectiveness of Fluocinolone Acetonide Implant versus Systemic Therapy for Noninfectious Intermediate, Posterior, and Panuveitis 10.1016/j.ophtha.2014.04.022
Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study 10.1002/pds.3623
Interobserver Agreement in Clinical Grading of Vitreous Haze Using Alternative Grading Scales 10.1016/j.ophtha.2014.02.018
Difluprednate 0.05% Versus Prednisolone Acetate 1% for Endogenous Anterior Uveitis: A Phase III, Multicenter, Randomized Study 10.1167/iovs.13-12660
Factors Predictive of Remission of New-Onset Anterior Uveitis 10.1016/j.ophtha.2013.09.041
Incidence of Visual Improvement in Uveitis Cases with Visual Impairment Caused by Macular Edema 10.1016/j.ophtha.2013.09.023
Risk of Choroidal Neovascularization among the Uveitides 10.1016/j.ajo.2013.04.040
Fluorescein Angiography versus Optical Coherence Tomography for Diagnosis of Uveitic Macular Edema 10.1016/j.ophtha.2013.01.069
Fundus image diagnostic agreement in uveitis utilizing free and open source software 10.1016/j.jcjo.2013.02.010
Response of Pediatric Uveitis to Tumor Necrosis Factor-alpha Inhibitors 10.3899/jrheum.121180
Risk of Elevated Intraocular Pressure and Glaucoma in Patients with Uveitis Results of the Multicenter Uveitis Steroid Treatment Trial 10.1016/j.ophtha.2013.01.025
Risk Factors for Loss of Visual Acuity among Patients with Uveitis Associated with Juvenile Idiopathic Arthritis: The Systemic Immunosuppressive Therapy for Eye Diseases Study 10.1016/j.ophtha.2012.07.052
Risk of Cataract in Persons with Cytomegalovirus Retinitis and the Acquired Immune Deficiency Syndrome 10.1016/j.ophtha.2012.05.044
Risk of Hypotony in Noninfectious Uveitis 10.1016/j.ophtha.2012.05.032
Epidemiology of Behcet Disease 10.3109/09273948.2012.723112
The Impact of Macular Edema on Visual Function in Intermediate, Posterior, and Panuveitis 10.3109/09273948.2012.658467
Risk of Corticosteroid-Induced Hyperglycemia Requiring Medical Therapy among Patients with Inflammatory Eye Diseases 10.1016/j.ophtha.2012.01.043
High-dose Intravenous Corticosteroids for Ocular Inflammatory Diseases 10.3109/09273948.2011.646382
Marginal Structural Models for Comparing Alternative Treatment Strategies in Ophthalmology using Observational Data 10.3109/09286586.2013.792939
Optical Coherence Tomography Evaluation in the Multicenter Uveitis Steroid Treatment (MUST) Trial 10.3109/09273948.2012.719258
Associations among Visual Acuity and Vision- and Health-Related Quality of Life among Patients in the Multicenter Uveitis Steroid Treatment Trial 10.1167/iovs.11-8259
Challenges in the design and implementation of the Multicenter Uveitis Steroid Treatment (MUST) Trial - lessons for comparative effectiveness trials 10.1177/1740774511423682
Risk of Relapse in Primary Acute Anterior Uveitis 10.1016/j.ophtha.2011.02.044
Morphologic Assessment for Glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) Trial 10.3109/09273948.2011.583376
Central corneal thickness and related factors in an elderly American Chinese population 10.1111/j.1442-9071.2010.02472.x
The Need for a Revised Approach to Epidemiological Monitoring of the Prevalence of Visual Impairment 10.3109/09286586.2011.588908
Randomized Comparison of Systemic Anti-inflammatory Therapy Versus Fluocinolone Acetonide Implant for Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment Trial 10.1016/j.ophtha.2011.07.027
Appropriate Use and Reporting of Uncontrolled Case Series in the Medical Literature 10.1016/j.ajo.2010.08.047
Adverse effects of smoking on patients with ocular inflammation 10.1136/bjo.2009.174466
Population-based prevalence of uveitis in Southern India 10.1136/bjo.2010.182311
Proof of Concept for Combined Insertion of Fluocinolone Acetonide and Glaucoma Drainage Implants for Eyes with Uveitis and Glaucoma 10.1016/j.ajo.2010.03.001
The Multicenter Uveitis Steroid Treatment Trial: Rationale, Design, and Baseline Characteristics 10.1016/j.ajo.2009.11.019
Mycophenolate Mofetil for Ocular Inflammation 10.1016/j.ajo.2009.09.026
Cyclosporine for Ocular Inflammatory Diseases 10.1016/j.ophtha.2009.08.010
Cyclophosphamide for Ocular Inflammatory Diseases 10.1016/j.ophtha.2009.06.060
Hypopyon in Patients with Uveitis 10.1016/j.ophtha.2009.07.025
Methotrexate for Ocular Inflammatory Diseases 10.1016/j.ophtha.2009.04.020
The Prevalence and Causes of Visual Loss Among HIV-Infected Individuals in Uganda 10.1097/QAI.0b013e3181c313f0
Uveitis in Patients with Autoimmune Hepatitis 10.1016/j.ajo.2008.08.019
Health Utilty among Community Dwelling Visually Impaired Individuals 10.1016/j.dhjo.2008.10.052
Azathioprine for Ocular Inflammatory Diseases 10.1016/j.ajo.2009.05.008
Disparities in Access to Medical Care for Individuals with Vision Impairment 10.3109/09286580902999439
Health Utilty among Community Dwelling Visually Impaired Individuals 10.1016/j.dhjo.2008.10.020
Interobserver Agreement in Grading Activity and Site of Inflammation in Eyes of Patients with Uveitis 10.1016/j.ajo.2008.06.004
Ocular Inflammation in Behcet Disease: Incidence of Ocular Complications and of Loss of Visual Acuity 10.1016/j.ajo.2008.06.019
Long-term Risk of Malignancy Among Patients Treated With Immunosuppressive Agents for Ocular Inflammation: A Critical Assessment of the Evidence 10.1016/j.ajo.2008.04.035
Medical management of human immunodeficiency virus infection 10.4103/0301-4738.42414
Early retinal vascular abnormalities in African-American cocaine users 10.1016/j.ajo.2008.05.037
Ocular immune reconstitution inflammatory syndromes 10.1097/COH.0b013e328302cc3d
Longitudinal study of the ocular complications of AIDS - 1. Ocular diagnoses at enrollment 10.1016/j.ophtha.2006.11.008
Longitudinal study of the ocular complications of AIDS - 2. Ocular examination results at enrollment 10.1016/j.ophtha.2006.07.065
Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS 10.1016/j.ophtha.2006.08.008
Methods for identifying long-term adverse effects of treatment in patients with eye diseases: The systemic immunosuppressive therapy for eye diseases (SITE) cohort study 10.1080/09286580701585892
Economic impact of visual impairment and blindness in the United States 10.1001/archopht.125.4.544
Incidence of ocular complications in patients with multibacillary leprosy after completion of a 2 year course of multidrug therapy 10.1136/bjo.2006.094870
Recurrent nodular scleritis preceding an adult TINU syndrome 10.1080/09273940600826612
Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy 10.1016/j.ophtha.2006.03.021
Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy 10.1016/j.ophtha.2006.03.022
Incidence of ocular morbidity among multibacillary leprosy patients during a 2 year course of multidrug therapy 10.1136/bjo.2005.084913
Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis 10.1016/j.ophtha.2005.10.067
The impact of anemia on energy and physical functioning in individuals with AIDS 10.1001/archinte.165.19.2229
Vogt-Koyanagi-Harada disease: Clinical outcomes 10.1016/j.ajo.2005.04.052
Retinal vascular occlusion in patients infected with human immunodeficiency virus 10.1097/00006982-200509000-00012
Birdshot retinochoroidopathy: Ocular complications and visual impairment 10.1016/j.ajo.2005.01.035
Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis 10.1016/j.ajo.2005.01.005
Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy 10.1016/j.ophtha.2004.10.049
Mycophenolate mofetil therapy for inflammatory eye disease 10.1016/j.ophtha.2005.02.020
Comparability of two fundus photograph reading centers in grading cytomegalovirus retinitis progression 10.1016/j.ajo.2003.10.002
Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection. 10.1016/j.ajo.2004.04.015
The prevalence of diabetic retinopathy among adult type 1 diabetic persons in the United States 10.1001/archopht.122.4.546
Incidence and management of cataract after retinal detachment repair with silicone oil in immune compromised patients with cytomegalovirus retinitis 10.1016/S0002-9394(03)00724-4
Mortality risk for patients with cytomegalovirus retinitis and acquired immune deficiency syndrome 10.1086/379077
The effect of cytomegalovirus retinitis on the quality of life of patients with AIDS in the era of highly active antiretroviral therapy 10.1016/S0161-6420(03)00089-7
Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome 10.1001/archopht.121.4.466
Cytomegalovirus resistance to ganciclovir and clinical outcomes of patients with cytomegalovirus retinitis 10.1016/S0002-9394(02)01759-2
Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy 10.1016/S0002-9394(01)01322-8
HIV and cytomegalovirus viral load and clinical outcomes in AIDS and cytomegalovirus retinitis patients: Monoclonal Antibody Cytomegalovirus Retinitis Trial 10.1097/00002030-200204120-00007
Incremental cost effectiveness of prophylaxis for cytomegalovirus disease in patients with AIDS 10.2165/00019053-200119120-00002
EFFECT OF VISUAL IMPAIRMENT ON NEUROPSYCHOLOGICAL TEST-PERFORMANCE 10.1080/01688639408402633
Immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis after highly active antiretroviral therapy 10.1016/S0002-9394(00)00356-1
Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population‐Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune‐Mediated Inflammatory Disease 10.1002/art.41709
Exudative Retinal Detachment in Ocular Inflammatory Diseases: Risk and Predictive Factors. 10.1016/j.ajo.2020.06.019
The Collaborative Ocular Tuberculosis Study (COTS)-1: A Multinational Review of 447 Patients with Tubercular Intermediate Uveitis and Panuveitis. 10.1080/09273948.2020.1808226
Seven-Year Outcomes of Uveitic Macular Edema: The Multicenter Uveitis Steroid Treatment Trial and Follow-up Study Results. 10.1016/j.ophtha.2020.08.035
HIV-induced Retinitis. 10.1080/09273948.2020.1808225
Prashant Garg
Garg Prashant
ORCID: 0000-0003-4989-2815
Outcome of transplanted donor corneas with more than 6 h of death-to-preservation time 10.4103/0301-4738.194338
Commentary: Pseudopestalotiopsis theae keratitis 10.4103/ijo.IJO_1490_18
Pythium insidiosum keratitis: Clinical profile and role of DNA sequencing and zoospore formation in diagnosis 10.1097/ICO.0000000000000349
Outcomes of Corneal Transplantation Using Donor Corneas Retrieved from Snakebite Victims 10.1097/ICO.0000000000001953
Microsporidial stromal keratitis successfully treated with medical therapy: A case report 10.1097/ICO.0b013e31821d876d
Oestrus ovis ophthalmomyiasis with keratitis 10.4103/0255-0857.71846
Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: Experience of over a decade 10.4103/0301-4738.53051
Clinical experience with N-butyl cyanoacrylate tissue adhesive in fungal keratitis 10.1097/00003226-200307000-00003
Fungal Infection of Sutureless Self-sealing Incision for Cataract Surgery 10.1016/S0161-6420(03)00861-3
Endophthalmitis after cataract surgery: Epidemiology, risk factors, and evidence on protection 10.1097/ICU.0000000000000326
Differential expression of antimicrobial peptides in corneal infection and regulation of antimicrobial peptides and reactive oxygen species by type III secretion system of Pseudomonas aeruginosa 10.1093/femspd/fty001
An outbreak of acute post-cataract surgery pseudomonas sp. endophthalmitis caused by contaminated hydrophilic intraocular lens solution 10.1016/j.ophtha.2011.09.031
Bilateral spontaneous rupture of the anterior capsule 10.1016/j.jcrs.2008.04.032
Lamellar Keratoplasty 10.1016/j.ophtha.2008.08.047
Optimizing diagnosis and management of Nocardia keratitis, scleritis, and endophthalmitis: 11-year microbial and clinical overview 10.1016/j.ophtha.2010.10.037
Corneal edema with dislocated anterior polar cataract 10.1016/S0002-9394(01)01324-1
High-resolution genome profiling differentiated Staphylococcus epidermidis isolated from patients with ocular infections and normal individuals 10.1167/iovs.06-1365
Repeat endothelial keratoplasty 10.1016/j.ophtha.2011.03.007
Infectious keratitis in climatic droplet keratopathy 10.1097/00003226-200007000-00009
Outcomes of Descemet's stripping endothelial keratoplasty in eyes with failed therapeutic penetrating keratoplasty 10.1111/aos.12033
Evaluation of medical college departments of ophthalmology in India 10.4103/0301-4738.44503
Role of confocal microscopy in the diagnosis of fungal and acanthamoeba keratitis 10.1016/j.ophtha.2010.05.018
Evaluation of three PCR assays for the detection of fungi in patients with mycotic keratitis 10.1136/bjophthalmol-2011-300207
Bilateral infectious keratitis after laser in situ keratomileusis: A case report and review of the literature 10.1016/S0161-6420(00)00435-8
Keratocyte loss in corneal infection through apoptosis: A histologic study of 59 cases 10.1186/1471-2415-4-16
Ciprofloxacin-resistant Pseudomonas keratitis 10.1016/S0161-6420(99)00717-4
Relation between uncorrected astigmatism and visual acuity in pseudophakia 10.1097/OPX.0b013e318288afb5
Clinical profile of graft detachment and outcomes of rebubbling after Descemet stripping endothelial keratoplasty 10.1136/bjophthalmol-2011-300155
Bilateral granular dystrophy: A clinicopathogenetic correlation after alcohol assisted debridement with phototherapeutic keratectomy 10.1016/j.mjafi.2012.08.023
Pupillary block glaucoma after tissue adhesive application and anterior chamber reformation with air 10.1097/00003226-200003000-00026
Ex vivo rabbit and human corneas as models for bacterial and fungal keratitis 10.1007/s00417-016-3546-0
Role of confocal microscopy in deep fungal keratitis 10.1097/ICO.0b013e318181cff7
Re: Said et al.: Collagen cross-linking with photoactivated riboflavin (PACK-CXL) for the treatment of advanced infectious keratitis with corneal melting (Ophthalmology 2014;121:1377-82) 10.1016/j.ophtha.2014.06.043
Uveitis-glaucoma-hyphaema syndrome with in-the-bag placement of intraocular lens 10.1136/bcr-2015-213745
Clinico-microbiological review of non-contact-lens-associated acanthamoeba keratitis 10.3109/08820538.2013.849270
Aspergillus fumigatus keratitis with wreath pattern infiltrates 10.1097/00003226-200107000-00019
PCR for the diagnosis and species identification of microsporidia in patients with keratitis 10.1111/j.1469-0691.2010.03152.x
Outcome of pterygium surgery: Analysis over 14 years 10.1038/sj.eye.6701728
The value of corneal transplantation in reducing blindness 10.1038/sj.eye.6701968
Alcohol epitheliectomy with mechanical debridement in a case of granular corneal dystrophy with r555w homozygous mutation of TGF B1 gene 10.4103/0301-4738.64126
Pathogenesis of pterygium: Role of Eph receptors and ligand ephrins,La pathogenèse du ptérygion : le rǒle des récepteurs Eph et des éphrines du ligand 10.3129/i09-038
Lasik infectious keratitis 10.1016/j.ophtha.2010.09.027
Leap forward in the treatment of Pythium insidiosum keratitis 10.1136/bjophthalmol-2017-311360
Comparison of in vitro susceptibilities of Gram-positive cocci isolated from ocular infections against the second and fourth generation quinolones at a tertiary eye care centre in South India 10.1038/eye.2009.29
Dictyostelium polycephalum infection of human cornea 10.3201/eid1610.100717
Clinical outcomes and risk factors for graft failure after deep anterior lamellar keratoplasty and penetrating keratoplasty for macular corneal dystrophy 10.1097/ICO.0000000000000327
Pseudomonas keratitis with satellite lesions: An unusual presentation 10.1136/bjo.2009.172171
Propionibacterium acnes as a cause of visually significant corneal ulcers 10.1097/00003226-200105000-00023
Prospective, Randomized Clinical Trial of Povidone-Iodine 1.25% Solution Versus Topical Antibiotics for Treatment of Bacterial Keratitis 10.1016/j.ajo.2016.10.004
Donor corneal button-related endophthalmitis after penetrating keratoplasty 10.1111/j.1442-9071.2010.02204.x
Risk factors and clinical outcomes of bacterial and fungal scleritis at a tertiary eye care hospital 10.4103/0974-9233.150634
Microbial analyses of contact lens-associated microbial keratitis 10.1097/OPX.0000000000000082
Trends in contact lens-associated microbial keratitis in Southern India 10.1016/S0161-6420(02)01283-6
Is microsporidial keratitis an emerging cause of stromal keratitis? - A case series study 10.1186/1471-2415-5-19
Correction: Alterations in the gut bacterial microbiome in fungal Keratitis patients(PLoS ONE (2018) 13:6 (e0199640) DOI: 10.1371/journal.pone.0199640) 10.1371/journal.pone.0211757
Keratomycosis: Clinical and microbiologic experience with dematiaceous fungi 10.1016/S0161-6420(99)00079-2
Novel drug delivery methods for the treatment of keratitis: moving away from surgical intervention 10.1080/17425247.2019.1690451
The epidemiological features and laboratory results of fungal keratitis: A 10-year review at a referral eye care center in South India 10.1097/00003226-200208000-00004
Differential expression of antimicrobial peptides in streptococcus pneumoniae keratitis and STAT3-dependent expression of LL-37 by streptococcus pneumoniae in human corneal epithelial cells 10.3390/pathogens8010031
Outcomes of Repeat Keratoplasty for Failed Therapeutic Keratoplasty 10.1016/j.ajo.2015.11.004
Re-appraisal of topical 1% voriconazole and 5% natamycin in the treatment of fungal keratitis in a randomised trial 10.1136/bjophthalmol-2014-306485
Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11 10.1136/jmg.2006.044644
In vitro antibiotic susceptibility of rapidly growing nontuberculous mycobacteria isolated from patients with microbial keratitis 10.3109/02713680903502258
Amphotericin B containing microneedle ocular patch for effective treatment of fungal keratitis 10.1016/j.ijpharm.2019.118808
Voriconazole for the treatment of refractory Aspergillus fumigatus keratitis 10.4103/0301-4738.40369
Binocular vision of bilaterally pseudophakic eyes with induced astigmatism 10.1097/OPX.0000000000000359
Diagnosis of microbial keratitis 10.1136/bjo.2010.182550
The International Council of Ophthalmology 360-degree assessment tool: development and validation 10.1016/j.jcjo.2017.09.002
Natamycin in the treatment of keratomycosis: Correlation of treatment outcome and in vitro susceptibility of fungal isolates 10.4103/0301-4738.86328
Mycobacterium chelonei masquerading as Corynebacterium in a case of infectious keratitis: A diagnostic dilemma 10.1097/00003226-199803000-00021
Antibiotic functionalised polymers reduce bacterial biofilm and bioburden in a simulated infection of the cornea 10.1039/c8bm00201k
Update on fungal keratitis 10.1097/ICU.0000000000000272
Microbial scleritis - Experience from a developing country 10.1038/sj.eye.6703099
Use of different stains for microscopic evaluation of corneal scrapings for diagnosis of microsporidial keratitis 10.1128/JCM.44.2.583-585.2006
Deep anterior lamellar keratoplasty in children 10.1016/j.ajo.2012.09.029
Traumatic fracture of posterior chamber intraocular lens 10.1016/j.jcrs.2007.07.054
Penetrating keratoplasty in children 10.1097/00003226-200003000-00004
Image quality analysis of pseudophakic eyes with uncorrected astigmatism 10.1097/OPX.0000000000000192
Corneal ulceration in the elderly in Hyderabad, south India 10.1136/bjo.84.1.54
Altered tear inflammatory profile in Indian keratoconus patients 10.4103/ijo.IJO_838_17
Fungal, Mycobacterial, and Nocardia infections and the eye: An update 10.1038/eye.2011.332
Diagnosis of herpes simplex virus-1 keratitis using Giemsa stain, immunofluorescence assay, and polymerase chain reaction assay on corneal scrapings 10.1136/bjo.88.1.142
3-Day treatment with azithromycin 1.5% eye drops versus 7-day treatment with tobramycin 0.3% for purulent bacterial conjunctivitis: Multicentre, randomised and controlled trial in adults and children 10.1136/bjo.2006.103556
Treatment outcome of Moraxella keratitis: Our experience with 18 cases a retrospective review 10.1097/00003226-199903000-00006
Alterations in the gut bacterial microbiome in fungal Keratitis patients 10.1371/journal.pone.0199640
Procurement, storage and utilization trends of eye banks in India 10.4103/ijo.IJO_1551_18
Histopathological evaluation of ocular microsporidiosis by different stains 10.1186/1472-6890-6-6
Outcomes of air descemetopexy for Descemet membrane detachment after cataract surgery 10.1016/j.jcrs.2012.01.030
Speciation and susceptibility of Nocardia isolated from ocular infections 10.1111/j.1469-0691.2009.03079.x
Collagen cross-linking for microbial keratitis 10.4103/meajo.MEAJO_305_16
Ocular nocardia infections with special emphasis on the cornea 10.1016/S0039-6257(00)00207-1
Coexistent congenital hereditary endothelial dystrophy and congenital glaucoma 10.1097/ICO.0b013e31804e4579
Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis 10.1136/bjo.84.10.1103
In vitro susceptibility of bacterial keratitis pathogens to ciprofloxacin: Emerging resistance 10.1016/S0161-6420(99)90008-8
Precut cornea for Descemet’s stripping endothelial keratoplasty: experience at a single eye bank 10.1007/s10792-016-0297-1
Long-term change in corneal astigmatism after sutureless cataract surgery 10.1016/j.ajo.2011.08.014
The Asia Cornea Society Infectious Keratitis Study: A Prospective Multicenter Study of Infectious Keratitis in Asia 10.1016/j.ajo.2018.07.040
Outcome of corneal transplant rejection: A 10-year study 10.1111/j.1442-9071.2005.01107.x
Aspergillus flavus keratitis after laser in situ keratomileusis 10.1016/S0002-9394(00)00406-2
Endothelial keratoplasty without stripping the Descemet's membrane 10.1136/bjo.2011.204008
Investigative modalities in infectious keratitis 10.4103/0301-4738.45512
Commentary: Pythium insidiosum keratitis 10.4103/ijo.IJO_1491_18
Spectrum and clinicomicrobiological profile of Nocardia keratitis caused by rare species of Nocardia identified by 16S rRNA gene sequencing 10.1038/eye.2009.299
Lamellar keratoplasty for the treatment of fungal keratitis 10.1097/00003226-200210000-00025
Corneal delivery of besifloxacin using rapidly dissolving polymeric microneedles 10.1007/s13346-017-0470-8
Clinical and microbiological profile of Bacillus keratitis 10.1097/00003226-200005000-00009
Microsporidial stromal keratitis: Clinical features, unique diagnostic criteria, and treatment outcomes in a large case series 10.1097/ICO.0000000000000939
Effect of Mucoadhesive Polymeric Formulation on Corneal Permeation of Fluoroquinolones 10.1089/jop.2018.0059
Is microsporidial keratitis a seasonal infection in India? 10.1111/j.1469-0691.2010.03084.x
Outcomes of keratoplasty in lattice corneal dystrophy in a large cohort of Indian eyes 10.4103/ijo.IJO_1150_17
Roles of adherence and matrix metalloproteinases in growth patterns of fungal pathogens in cornea 10.1080/02713680600669397
Microbial keratitis following vegetative matter injury 10.1007/s10792-012-9643-0
Epithelial infectious crystalline keratopathy 10.1016/S0002-9394(00)00712-1
Training the eye care team: Principles and practice 10.4103/0974-9233.129757
Fungal keratitis after laser in situ keratomileusis 10.1016/S0886-3350(99)00459-9
Non-contact lens related Acanthamoeba keratitis 10.4103/ijo.IJO_826_17
Phenotypic and genotypic characterization of coagulase negative staphylococci (CoNS) other than staphylococcus epidermidis isolated from ocular infections 10.1167/iovs.11-7777
Corneal transplantation in disease affecting only one eye: Does it make a difference to habitual binocular viewing? 10.1371/journal.pone.0150118
Surgical management of fungal keratitis 10.1080/17469899.2018.1555032
Microsporidia infection of the cornea-a unique and challenging disease 10.1097/ICO.0b013e3182a2c91f
Analysis of resident-performed manual small incision cataract surgery (MSICS): An efficacious approach to mature cataracts 10.1007/s10792-012-9605-6
Re: Ang et al: Descemet's stripping automated endothelial keratoplasty with anterior chamber intraocular lenses: Complications and 3-year outcomes 10.1136/bjophthalmol-2014-305753
Efficacy of Topical Miltefosine in Patients with Acanthamoeba Keratitis: A Pilot Study 10.1016/j.ophtha.2018.12.028
Decreased susceptibility to quinolones in methicillin-resistant Staphylococcus aureus isolated from ocular infections at a tertiary eye care centre 10.1136/bjo.2010.179747
Treatment and outcome of Nocardia keratitis 10.1097/00003226-200107000-00003
Corneal collagen cross-linkage,inkeratoconus 10.1136/bjophthalmol-2012-302322
Microsporidial keratitis in India: 16s rRNA gene-based PCR assay for diagnosis and species identification of microsporidia in clinical samples 10.1167/iovs.06-0376
Pythium Insidiosum Keratitis: Histopathology and Rapid Novel Diagnostic Staining Technique 10.1097/ICO.0000000000001463
Use of 18S rRNA gene-based PCR assay for diagnosis of Acanthamoeba keratitis in non-contact lens wearers in India 10.1128/JCM.41.7.3206-3211.2003
KOH mount as an aid in the management of infectious keratitis at secondary eye care centre 10.1136/bjophthalmol-2017-310241
Nocardia infection following phacoemulsification 10.4103/0301-4738.29498
Erratum: Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11 (Journal of Medical Genetics (2007) 44, (64-68)) 10.1136/jmg.2006.044644corr1
Pigmented plaque presentation of dematiaceous fungal keratitis: A clinicopathologic correlation 10.1097/01.ico.0000126318.90271.3c
Alterations in gut bacterial and fungal microbiomes are associated with bacterial Keratitis, an inflammatory disease of the human eye 10.1007/s12038-018-9798-6
Atypical herpes simplex keratitis (HSK) presenting as a perforated corneal ulcer with a large infiltrate in a contact lens wearer: Multinucleated giant cells in the Giemsa smear offered a clue to the diagnosis 10.1186/1471-2415-1-1
Comparison of clinical and microbiological profiles in smear-positive and smear-negative cases of suspected microbial keratitis 10.4103/0301-4738.29490
Posterior capsule dehiscence during phacoemulsification and manual extracapsular cataract extraction: Comparison of outcomes 10.1016/S0886-3350(02)01696-6
Endothelial keratoplasty in the management of irido-corneal endothelial syndrome 10.1038/eye.2012.298
Clinical and Antibacterial Efficacy and Safety of Besifloxacin Ophthalmic Suspension Compared With Moxifloxacin Ophthalmic Solution 10.1097/APO.0000000000000055
Broken suture - Predisposing factor for Nocardia keratitis 10.1038/eye.2000.31
Evaluation of agent and host factors in progression of mycotic keratitis: A histologic and microbiologic study of 167 corneal buttons 10.1016/S0161-6420(02)01088-6
Confocal Microscopy for Nocardia Keratitis 10.1016/j.ophtha.2006.03.054
Sutureless wound infection by unusual acid-fast organisms 10.1097/ICO.0b013e318166efdf
Can we apply the results of the Steroid Corneal Ulcer Trial to Nocardia infections of the cornea? 10.1586/eop.12.72
Primary graft failure after big bubble deep anterior lamellar keratoplasty in macular corneal dystrophy 10.4103/ijo.IJO_220_18
Effect of transfer of donor corneal tissue from McCarey-Kaufman medium to Optisol on corneal endothelium 10.4103/ijo.IJO_1135_17
Microsporidial keratoconjunctivitis in an immunocompetent patient with a past history of laser in situ keratomilieusis surgery 10.4103/0255-0857.90189
Microbial keratitis after LASIK 10.3928/1081597X-20100224-07
Thirty years of eye bank experience at a single centre in India 10.1007/s10792-019-01164-y
Evaluation of corneal scraping smear examination methods in the diagnosis of bacterial and fungal keratitis: A survey of eight years of laboratory experience 10.1097/00003226-200210000-00002
Characterization of Ocular Clinical Isolates of Pseudomonas aeruginosa from Non-Contact Lens Related Keratitis Patients from South India 10.3390/microorganisms8020260
The epidemiological features and laboratory results of fungal keratitis - A 10-year review at a referral eye care center in south India 10.1097/01.ICO.0000022924.90020.30
The value of corneal transplantation in reducing blindness 10.1038/SI.EYE.6701968
Bilateral peripheral infiltrative keratitis after LASIK 10.3928/1081-597X-20050701-18
Acanthamoeba keratitis after LASIK 10.3928/1081-597X-20060601-17
A cluster of nocardial keratitis after LASIK 10.3928/1081-597X-20070301-17
Authors reply 10.1093/SW/25.4.335-A
Investigative modalities in infectious keratitis 10.4103/0301-4738.40359
Clinical, Microbiological Profile and Treatment Outcome of Ocular Infections Caused by Achromobacter xylosoxidans 10.1097/ICO.0B013E3181A1658F
Endothelial Keratoplasty: A Review of Indications at a Tertiary Eye Care Centre in South India 10.1097/APO.0B013E3182A75304
Microbial Keratitis Due to Aeromonas Species at a Tertiary Eye Care Center in Southern India 10.1097/APO.0000000000000018
Alterations in the Ocular Surface Fungal Microbiome in Fungal Keratitis Patients 10.3390/MICROORGANISMS7090309
Infectious corneal ulceration: a proposal for neglected tropical disease status 10.2471/BLT.19.232660
Management of severe Acanthamoeba keratitis and complicated cataract following laser in situ keratomileusis 10.4103/IJO.IJO_492_19
Outcome of therapeutic deep anterior lamellar keratoplasty in advanced Acanthamoeba keratitis 10.4103/IJO.IJO_307_19
Cyclam-based antibacterial molecules eradicate Gram-negative superbugs with potent efficacy against human corneal infection 10.1039/C9CC06967D
Corneal Infection Models: Tools to Investigate the Role of Biofilms in Bacterial Keratitis 10.3390/cells9112450
A randomized masked pilot clinical trial to compare the efficacy of topical 1% voriconazole ophthalmic solution as monotherapy with combination therapy of topical 0.02% polyhexamethylene biguanide and 0.02% chlorhexidine in the treatment of Acanthamoeba keratitis 10.1038/s41433-020-1109-4
Response to ‘Comment on: ‘A randomized masked pilot clinical trial to compare the efficacy of topical 1% Voriconazole ophthalmic solution as monotherapy to combination therapy with topical 0.02% Polyhexamethylene biguanide and 0.02% Chlorhexidine in the treatment of Acanthamoeba keratitis’’ 10.1038/s41433-021-01401-8
Srinivasan M
M Srinivasan
ORCID: 0000-0003-4413-2892
Antioxidant Vitamins for Cataracts: 15-Year Follow-up of a Randomized Trial 10.1016/j.ophtha.2020.01.050
Supra-Descemetic Venting Incision in the Management of Spontaneous Descemet Membrane Detachment in an Old Penetrating Keratoplasty Graft. 10.1097/ico.0000000000002664
Infectious corneal ulceration: a proposal for neglected tropical disease status 10.2471/BLT.19.232660
Predictors of Corneal Perforation or Need for Therapeutic Keratoplasty in Severe Fungal Keratitis: A Secondary Analysis of the Mycotic Ulcer Treatment Trial II 10.1001/jamaophthalmol.2017.2914
Toxic Keratitis After Application of Custard Apple Seed for Head Lice Infestation 10.1097/ICO.0000000000001981
Village-Integrated Eye Worker trial (VIEW): rationale and design of a cluster-randomised trial to prevent corneal ulcers in resource-limited settings 10.1136/bmjopen-2018-021556
Pythium keratitis in South India: Incidence, clinical profile, management, and treatment recommendation 10.4103/ijo.IJO_445_18
Therapeutic Penetrating Keratoplasty Button Cultures in The Mycotic Ulcer Treatment Trial II: A Randomized Trial Comparing Oral Voriconazole Versus Placebo 10.1016/j.ajo.2018.05.007
Visual Impairment in Fungal Versus Bacterial Corneal Ulcers 4 Years After Successful Antimicrobial Treatment 10.1016/j.ajo.2019.03.010
Regression Discontinuity and Randomized Controlled Trial Estimates: An Application to The Mycotic Ulcer Treatment Trials 10.1080/09286586.2018.1469156
Ocular manifestations of isolated corneal bee sting injury, management strategies, and clinical outcomes 10.4103/ijo.IJO_600_17
Microsporidial infection masquerading as graft rejection post-Descemet's stripping automated endothelial keratoplasty 10.4103/ijo.IJO_295_17
Reply to Comment on: Fungal keratitis: The Aravind Experience 10.4103/ijo.IJO_1163_17
Natural History and Predictors of Progression to Sjögren's Syndrome Among Participants of the Sjögren's International Collaborative Clinical Alliance Registry 10.1002/acr.23264
Fungal keratitis: The Aravind experience 10.4103/ijo.IJO_821_17
Management of Extraocular Infections 10.1007/s12098-017-2409-y
Clinical and demographic study of microsporidial keratoconjunctivitis in South India: a 3-year study (2013-2015) 10.1136/bjophthalmol-2016-309845
Adjunctive Oral Voriconazole Treatment of Fusarium Keratitis: A Secondary Analysis From the Mycotic Ulcer Treatment Trial II 10.1001/jamaophthalmol.2017.0616
Genome-Wide Association Analysis Reveals Genetic Heterogeneity of Sjögren's Syndrome According to Ancestry 10.1002/art.40040
The Utility of Repeat Culture in Fungal Corneal Ulcer Management: A Secondary Analysis of the MUTT-I Randomized Clinical Trial 10.1016/j.ajo.2017.03.032
Effect of Oral Voriconazole on Fungal Keratitis in the Mycotic Ulcer Treatment Trial II (MUTT II): A Randomized Clinical Trial 10.1001/jamaophthalmol.2016.4096
Effect of pretreatment with antifungal agents on clinical outcomes in fungal keratitis 10.1111/ceo.12794
Environmentally Endemic Pseudomonas aeruginosa Strains with Mutations in lasR Are Associated with Increased Disease Severity in Corneal Ulcers 10.1128/mSphere.00140-16
Changing Azole Resistance: A Secondary Analysis of the MUTT I Randomized Clinical Trial 10.1001/jamaophthalmol.2016.0530
Risk factors for low vision related functioning in the Mycotic Ulcer Treatment Trial: a randomised trial comparing natamycin with voriconazole 10.1136/bjophthalmol-2015-306828
Inter-grader Agreement of the Ocular Staining Score in the Sjögren's International Clinical Collaborative Alliance (SICCA) Registry 10.1016/j.ajo.2015.08.021
The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial 10.1016/j.ajo.2013.09.025
Acanthamoeba, fungal, and bacterial keratitis: a comparison of risk factors and clinical features 10.1016/j.ajo.2013.08.032
Association of Dry Eye Tests With Extraocular Signs Among 3514 Participants in the Sjögren's Syndrome International Registry 10.1016/j.ajo.2016.09.013
Trends in antibiotic resistance in bacterial keratitis isolates from South India 10.1136/bjophthalmol-2016-308487
Association of Biofilm Formation, Psl Exopolysaccharide Expression, and Clinical Outcomes in Pseudomonas aeruginosa Keratitis: Analysis of Isolates in the Steroids for Corneal Ulcers Trial 10.1001/jamaophthalmol.2015.5956
Early addition of topical corticosteroids in the treatment of bacterial keratitis 10.1001/jamaophthalmol.2014.292
Vision-Related Quality-of-Life Outcomes in the Mycotic Ulcer Treatment Trial I: A Randomized Clinical Trial 10.1001/jamaophthalmol.2015.0319
Visual recovery in treated bacterial keratitis 10.1016/j.ophtha.2013.12.041
Microsporidial stromal keratitis masquerading as acute graft rejection 10.1097/ICO.0000000000000337
The SSB-positive/SSA-negative antibody profile is not associated with key phenotypic features of Sjögren's syndrome 10.1136/annrheumdis-2014-206683
Trends in bacterial and fungal keratitis in South India, 2002-2012 10.1136/bjophthalmol-2014-305000
The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole 10.1001/jamaophthalmol.2013.1497
Comparison of natamycin and voriconazole for the treatment of fungal keratitis 10.1001/archophthalmol.2010.102
The steroids for corneal ulcers trial: study design and baseline characteristics 10.1001/archophthalmol.2011.303
Genetic analysis of patients with Fuchs endothelial corneal dystrophy in India 10.1186/1471-2415-10-3
A subset of human limbal epithelial cells with greater nucleus-to-cytoplasm ratio expressing high levels of p63 possesses slow-cycling property 10.1097/ICO.0b013e3181814ce6
Mooren''s ulcer following extracapsular cataract extraction 10.1177/112067210801800306
Identification of mutations in the SLC4A11 gene in patients with recessive congenital hereditary endothelial dystrophy 10.1001/archopht.126.5.700
A method to isolate human limbal basal cells enriched for a subset of epithelial cells with a large nucleus/cytoplasm ratio expressing high levels of p63 10.1002/jemt.20573
Does in vitro susceptibility predict clinical outcome in bacterial keratitis? 10.1016/j.ajo.2007.11.004
Investigation of VSX1 sequence variants in South Indian patients with sporadic cases of keratoconus 10.1186/1756-0500-6-103
Nocardia keratitis: clinical course and effect of corticosteroids 10.1016/j.ajo.2012.06.001
Predictors of outcome in fungal keratitis 10.1038/eye.2012.99
Differentiation of etiologic agents of bacterial keratitis from presentation characteristics 10.1007/s10792-012-9601-x
Seasonal trends of microbial keratitis in South India 10.1097/ICO.0b013e31825694d3
Corticosteroids for bacterial corneal ulcers 10.1136/bjo.2008.147298
Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial 10.1097/ICO.0b013e31823f8ae0
Acanthamoeba keratitis in South India: a longitudinal analysis of epidemics 10.3109/09286586.2011.645990
Distinguishing infective versus noninfective keratitis 10.4103/0301-4738.40358
Relationship of in vitro susceptibility to moxifloxacin and in vivo clinical outcome in bacterial keratitis 10.1093/cid/cis189
Corticosteroids for bacterial keratitis: the Steroids for Corneal Ulcers Trial (SCUT) 10.1001/archophthalmol.2011.315
Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis 10.1001/archopht.125.6.789
Microbial keratitis in South India: influence of risk factors, climate, and geographical variation 10.1080/09286580601001347
Nocardia keratitis: species, drug sensitivities, and clinical correlation 10.1097/ICO.0b013e318033d853
Economic analysis of corneal ulcers in South India 10.1097/ICO.0b013e31802b36dc
A study of the spectrum of Acanthamoeba keratitis: a three-year study at a tertiary eye care referral center in South India 10.4103/0301-4738.29493
Hookworm infestation as a risk factor for Mooren's ulcer in South India 10.1016/j.ophtha.2006.08.014
Clinical characteristics of Mooren's ulcer in South India 10.1136/bjo.2006.105452
Corneal ulceration in south-east Asia III: prevention of fungal keratitis at the village level in south India using topical antibiotics 10.1136/bjo.2006.103028
Risk factors for treatment outcome in fungal keratitis 10.1016/j.ophtha.2005.10.063
Microbiological diagnosis of infective keratitis: comparative evaluation of direct microscopy and culture results 10.1136/bjo.2006.096230
Herpes simplex keratitis and visual impairment: a case series 10.4103/0301-4738.21610
Rhodococcus ruber as a cause of keratitis 10.1097/01.ico.0000170690.59960.8c
High expression of p63 combined with a large N/C ratio defines a subset of human limbal epithelial cells: implications on epithelial stem cells 10.1167/iovs.05-0343
Postcataract endophthalmitis in South India incidence and outcome 10.1016/j.ophtha.2005.05.020
Nocardia endophthalmitis after cataract surgery: clinicomicrobiological study 10.1016/j.ajo.2004.12.005
Susceptibility trends of pseudomonas species from corneal ulcers 10.4103/0255-0857.16588
A cluster of cases of Mycobacterium chelonei keratitis following penetrating keratoplasty 10.4103/0301-4738.15292
Antioxidants in prevention of cataracts in South India: methodology and baseline data* 10.1080/09286580500477366
Cataract progression in India 10.1136/bjo.81.10.896
Concurrent use of 5% natamycin and 2% econazole for the management of fungal keratitis 10.1097/01.ico.0000134193.64357.82
Fixed dilated pupil (Urrets-Zavalia syndrome) in corneal dystrophies 10.1097/00003226-200401000-00014
A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis 10.1136/bjo.87.10.1235
An outbreak of trematode-induced granulomas of the conjunctiva 10.1016/s0161-6420(01)00604-2
Congenital corneal anesthesia: a series of four case reports 10.1097/00003226-200103000-00018
Bacteriologic and clinical efficacy of ofloxacin 0.3% versus ciprofloxacin 0.3% ophthalmic solutions in the treatment of patients with culture-positive bacterial keratitis 10.1097/00003226-200103000-00013
Mooren ulcer in South India: serology and clinical risk factors 10.1016/s0002-9394(99)00162-2
Epidemiology and aetiological diagnosis of corneal ulceration in Madurai, south India 10.1136/bjo.81.11.965
Acanthamoeba keratitis in non-contact lens wearers 10.1001/archopht.1990.01070070062035